betaFeedback

WorksComputer Science

MI-Hyper: Generating Multiple Instance Models for Weight Space Transfer Learning in Histopathology via Mixed Tasks Pretrained HyperNetwork

Abstract

Zero-shot whole-slide image (WSI) prediction aims to generalize to new pathology tasks without parameter updates at deployment. MI-Zero makes these predictions by pooling patch-text similarities. Conditional weight generation, combined with supervision from diverse pathology tasks, offers an alternative: learning to construct predictive rules from task descriptions. We introduce MI-Hyper, a hypernetwork pretrained across mixed tasks to generate the aggregation and classification weights of multiple instance learning (MIL) models. We first train the generator and a shared MIL basis jointly using source labels. We then freeze the basis and refine the generator. The generated task weights are reused across cases. Across 308 tasks from 52 pathology datasets, MI-Hyper improves mean AUC, balanced accuracy and macro-F1 over MI-Zero by 1.85, 1.17 and 0.57 percentage points, respectively. On some molecular prediction tasks, both AUC and balanced accuracy improve by more than 20 points. These results support task-conditioned weight generation as a promising approach to weight-space transfer for long-sequence modeling.

Introduction

Zero-shot whole-slide image (WSI) prediction seeks to reuse a trained system for new pathology tasks without task-specific optimization at deployment. Because the same slide can support subtyping, grading and molecular prediction, the relevant tissue evidence depends on the endpoint. A zero-shot predictor must therefore select and combine patterns across long patch sequences according to the task.

Pathology foundation models provide a common starting point through reusable representations at the patch and whole-slide levels [11, 32]. For patch-based prediction, multiple instance learning (MIL) converts a bag of representations into a slide-level output through aggregation and classification [18, 30]. Aggregation and classification parameters determine how tissue features contribute to a particular endpoint. The remaining question is how to obtain these parameters for a new task without additional target-task optimization.

Language provides a natural interface for specifying tasks through class descriptions. MI-Zero uses this interface to compare patch and class-text representations in a shared embedding space, then pools their similarities into slide-level predictions [31]. Changing the descriptions changes the similarity scores, which a predefined operator pools. This language interface also suggests a complementary route: generating the parameters that govern MIL aggregation and classification from the descriptions.

Conditional weight generation provides a mechanism for learning this mapping from descriptions to predictors. Hypernetworks generate model parameters from conditioning information, and language-conditioned methods extend this principle to classifiers and adaptation weights [2, 6, 14]. Meanwhile, labeled pathology datasets cover multiple organs and prediction endpoints [45, 52]. These source labels can supervise prediction by generated models, allowing the description-to-weight mapping to be learned across tasks. This provides a basis for studying transfer through the weights of generated MIL predictors.

Building on this opportunity, we introduce MI-Hyper, a hypernetwork pretrained across mixed tasks to construct MIL predictors from task and class descriptions. Figure 1 contrasts MI-Zero’s similarity pooling with MI-Hyper’s weight generation, while Figure 2 presents the training and deployment framework. We first train the generator and a shared MIL basis through source-label prediction. With the basis fixed, we then refine the dual-text generator using source labels and text-consistency objectives. At deployment, MI-Hyper generates task-specific aggregation and classification weights for each text condition and reuses them across cases. The generated parameters are shared within a task, but attention is computed from each case’s tissue content. Their number is independent of bag length, so task-level model generation is separate from computation over each case’s complete patch sequence. This separation allows us to study weight-space transfer in long-sequence modeling.

Figure 1. Constructing predictors from tiled WSIs. (a) MI-Zero pools patch–text similarity scores. (b) MI-Hyper constructs an MIL predictor using generated weights.

Figure 2. Mixed-task learning and zero-shot deployment of MI-Hyper. (a) The task registry covers 52 datasets, 308 tasks and 112 semantic groups. The global training partition contains 20,420 patients and 111,151 task–case pairs. Each fold optimizes on eligible source tasks and holds out target task IDs; cases may recur across source and target tasks. (b) Joint source-label learning is followed by fixed-basis refinement with cross-entropy and auxiliary losses (Eq. (8)). (c) Task and class descriptions generate the aggregation query and classifier weights, which are reused across cases without target-task parameter updates.

We train MI-Hyper with five folds over 112 semantic groups and compare it with MI-Zero on 308 tasks from 52 pathology datasets. Target task IDs are held out from source optimization and checkpoint selection, while cases can recur across tasks. On the complete query set, MI-Hyper improves mean AUC, balanced accuracy and macro-F1 by 1.85, 1.17 and 0.57 percentage points, respectively. On some molecular prediction tasks, both AUC and balanced accuracy improve by more than 20 points. To understand these results, we organize performance by endpoint, anatomy, bag size and dataset source, then examine individual tasks and the relation between generated queries and spatial attention.

Our contributions are threefold:

  • We introduce MI-Hyper, which learns to generate task-specific MIL aggregation and classification weights from descriptions, separating predictor construction from case-level sequence processing.

  • We train the generator on labels from mixed source tasks through joint learning and fixed-basis refinement. The generated parameters are reused across cases, while chunked execution processes each complete patch sequence.

  • We evaluate this framework on 308 tasks from 52 pathology datasets, combining overall and task-level comparisons with analyses of generated queries and spatial attention.

Related Work

Pathology foundation models and MIL. WSI analysis spans cancer detection and molecular prediction, with reliable evaluation depending on accurate reference labels [5, 10, 22, 27]. Large-scale self-supervision, exemplified by UNI and Virchow, and contrastive learning produce reusable patch representations [8, 39, 41, 42, 53]. Representation learning also encompasses cell-level morphology [9], global slide context [7, 43, 44] and multimodal learning from reports or molecular measurements [11, 36, 47]. To obtain slide predictions from patch features, ABMIL uses attention, CLAM uses clustering-constrained attention, and TransMIL models correlations among instances [18, 30] [38]. Related variants incorporate dual streams, agent tokens, graph interactions and distillation [13, 24, 25, 26, 48]. Conventional task-supervised MIL fits aggregation and classification parameters to each downstream task. MI-Hyper instead generates these parameters from task descriptions.

Language-guided prediction. Visual–semantic and contrastive learning align images with textual descriptions [34, 35]. Learnable and image-conditioned prompts further adapt language-guided prediction to general visual recognition [50, 51]. In biomedicine, pathology-specific models such as CONCH and broader biomedical models learn image–text alignment from paired data [17, 20, 32, 49]. At the slide level, reports and clinical dialogue provide language supervision for attention and representation learning [11, 37, 40]. For zero-shot WSI prediction, MI-Zero pools similarities between patches and text [31]. Our MI-Zero implementation uses the same frozen image and text encoders as MI-Hyper. It applies CONCH-Z’s contrastive visual projection before pooling patch–text similarities, whereas MI-Hyper uses the patch features for MIL prediction.

Conditional weight generation. Early zero-shot recognition methods predicted classifiers and convolutional filters from text [3, 12]. More generally, hypernetworks generate model parameters from conditioning information [4, 14]. This mechanism generates adapters and prompts [15, 21], supports instruction conditioning [19], and can produce low-rank adaptation weights based on LoRA [6, 16]. Language can also guide adaptation in a hypernetwork’s latent space [33] or determine an image encoder’s normalization parameters [1]. Set representations encode unordered class descriptions [23, 46], while permutation-equivariant prediction preserves their correspondence with class outputs [2]. MI-Hyper studies this description-to-weight mapping for MIL predictors operating on long WSI patch sequences.

Methods of MI-Hyper

Figure 2 shows how source labels supervise generated MIL models through two-stage training. At deployment, each predictor reuses its generated parameters across cases and aggregates each case’s complete patch sequence.

Problem Formulation

We represent a case as a bag of patch features extracted by a frozen encoder, X={xi}i=1NX = \{x_i\}_{i=1}^{N}, where xi∈Rdx_i \in\mathbb{R}^{d}. A bag may contain patches from one or more slides of the same case, and its length NN varies with tissue coverage. A prediction task τ\tau is defined by an ordered vocabulary of CτC_{\tau} classes and a text condition cτc_{\tau} comprising class descriptions and additional task context.

Given cτc_{\tau}, the hypernetwork generates task-specific parameters and assembles them with shared components to form an MIL predictor:

θτ=Hϕ(cτ),Wτ=Aν(W0,θτ),\theta_{\tau}=H_{\phi}(c_{\tau}),\qquad W_{\tau}=A_{\nu}(W_{0},\theta_{\tau}),
pτ(y∣X)=fν(X;Wτ).(1)p_{\tau}(y\mid X)=f_{\nu}(X;W_{\tau}). \tag*{(1)}

Here, ϕ\phi denotes the generator parameters, W0W_{0} contains components shared across tasks, and ν\nu specifies the predictor parameterization and assembly rule. We instantiate this formulation with a gated MIL predictor.

Prior hypernetwork-based transfer for WSI prognosis uses WSI-conditioned mixing and sparse aggregation of cancer-specific task vectors [28]. MI-Hyper instead conditions its generator on task and class descriptions, allowing the generated parameters to be reused across cases of the same task.

Conditional Weight Generation

Our gated MIL implementation uses frozen CONCH v1.5 patch features and CONCH-Z text embeddings, both of width 768 [37]. Class names specify the required distinctions, and background descriptions place the prediction endpoint in context. A learnable adapter then maps normalized text embeddings to 256-dimensional representations. For task context sτs_{\tau} and class description sτjs_{\tau j},

tτ=gϕ(e(sτ)),zτj=gϕ(e(sτj)),t_{\tau}=g_{\phi}(e(s_{\tau})),\qquad z_{\tau j}=g_{\phi}(e(s_{\tau j})),
zˉτ=1Cτ∑j=1Cτzτj(2)\bar{z}_{\tau}=\frac{1}{C_{\tau}}\sum_{j=1}^{C_{\tau}}z_{\tau j} \tag*{(2)}

where ee is the frozen text encoder and gϕg_{\phi} is the trainable adapter. The class-name branch generates the attention query from task context and a symmetric class summary. The shared decoder also receives the individual class representation and outputs its classifier row and bias:

qτ=Dϕq([tτ;zˉτ]),q_{\tau}=D_{\phi}^{q}([t_{\tau};\bar{z}_{\tau}]),
(wτj,bτj)=Dϕcls([tτ;zτj,zˉτ]).(3)(w_{\tau j},b_{\tau j})=D_{\phi}^{\mathrm{cls}}([t_{\tau};z_{\tau j},\bar{z}_{\tau}]). \tag*{(3)}

The query has width a=128a=128, and each classifier row has width h=256h=256. Stacking the class outputs gives Wτcls∈RCτ×hW_{\tau}^{\mathrm{cls}}\in\mathbb{R}^{C_{\tau}\times h} and bτ∈RCτb_{\tau}\in\mathbb{R}^{C_{\tau}}. The symmetric class summary makes the query invariant to class order, while classifier rows follow the order of their descriptions. The shared decoder therefore accommodates tasks with different class counts.

The dual-text generator extends the class-name branch with a joint class-name–morphology branch. This branch has a separate trainable text adapter for morphology descriptions and a fusion adapter that combines each class’s name and morphology representations. An availability mask excludes missing or unverified morphology descriptions before class summarization and nonlinear interaction. A text-conditioned gate then linearly interpolates the queries, classifier rows and biases of the two branches, component by component. The gate receives task and class text representations, pairwise similarity statistics within and between the name and morphology embeddings, and morphology availability. It does not receive patch features from the query case. Text therefore determines the task weights before case features enter MIL prediction.

MIL Prediction

To apply the generated parameters, the shared MIL basis first projects patch features into a common representation space and computes gated attention features:

vi=ReLU⁡(Pxi+bP),gi=tanh⁡(Vvi+bV)⊙sigmoid⁡(Uvi+bU).(4)v_i = \operatorname{ReLU}(P x_i + b_P), \qquad g_i = \tanh(V v_i + b_V) \odot\operatorname{sigmoid}(U v_i + b_U). \tag*{(4)}

The projection and gated attention parameters belong to the shared basis W0W_0. The generated query then scores each patch to obtain globally normalized attention and an aggregated case representation:

ri=qτTgi,r_i = q_\tau^{\mathsf{T}} g_i,
αi=exp⁡(ri)∑j=1Nexp⁡(rj),vX=∑i=1Nαivi.(5)\alpha_i = \frac{\exp(r_i)}{\sum_{j=1}^{N} \exp(r_j)}, \qquad v_X = \sum_{i=1}^{N} \alpha_i v_i. \tag*{(5)}

The generated classifier maps this representation to class probabilities:

pτ(y∣X)=softmax⁡(WτclsvX+bτ).(6)p_\tau(y \mid X) = \operatorname{softmax}\left(W_\tau^{\mathrm{cls}} v_X + b_\tau\right). \tag*{(6)}

All classes share one task-conditioned attention distribution, so each bag is scored and pooled once per text condition. Although qτq_\tau, WτclsW_\tau^{\mathrm{cls}} and bτb_\tau are reused across cases, attention scores are recomputed from the patches of each case. We center the classifier rows and biases along the class dimension to remove a common logit offset. Since all classes use the same aggregated representation, this operation preserves softmax probabilities.

Mixed-Task Learning

Source optimization tasks (SOURCE-FIT) supply labeled cases, while separate source tasks (SOURCE-DEV) select checkpoints. Neither role includes the target task IDs for that fold. For a source task τ\tau, text condition cτc_\tau and case–label pair (X,y)(X, y), the prediction objective is

Lsrc(W0,ϕ)=E(τ,cτ,X,y)∼Dsrc[−log⁡pτ(y∣X)].(7)\mathcal{L}_{\mathrm{src}}(W_0,\phi) = \mathbb{E}_{(\tau,c_\tau,X,y)\sim\mathcal{D}_{\mathrm{src}}} \left[-\log p_\tau(y \mid X)\right]. \tag*{(7)}

Training cycles through source tasks, balances classes within each task and samples at most 2048 stored patches per case. Both pretrained encoders remain frozen.

Source cross-entropy jointly trains a randomly initialized generator and shared MIL basis; the pretrained encoders remain frozen. This stage uses canonical task contexts and class-specific morphology descriptions. SOURCE-DEV selects checkpoints by task-average AUC under the canonical condition, without parameter updates. The selected generator initializes the class-name branch, and a copy of its text adapter initializes the morphology branch. Refinement fixes the projection and gated attention basis W0W_0.

During fixed-basis refinement, each source case is evaluated using a canonical text condition and an augmented condition. Their mean cross-entropy defines LCE\mathcal{L}_{\mathrm{CE}}, the Jensen–Shannon divergence between their prediction distributions defines LJS\mathcal{L}_{\mathrm{JS}}, and the squared difference between their predicted gate scores defines Lgate\mathcal{L}_{\mathrm{gate}}. A task proxy computed from source-training case features also supervises the predicted gate score through mean squared error, denoted Lproxy\mathcal{L}_{\mathrm{proxy}}. This proxy uses between-class and within-class dispersion of source-case mean patch features and is applied only when sample support is valid. This source-derived proxy regularizes the gate; inference still computes the gate from text alone. The refinement objective is

Lrefine=LCE+0.1LJS+0.01Lgate+0.1Lproxy.(8)\mathcal{L}_{\mathrm{refine}} = \mathcal{L}_{\mathrm{CE}} + 0.1\mathcal{L}_{\mathrm{JS}} + 0.01\mathcal{L}_{\mathrm{gate}} + 0.1\mathcal{L}_{\mathrm{proxy}}. \tag*{(8)}

Both stages use source-label supervision; refinement also encourages consistent predictions and gate scores under text augmentation. Each stage runs for 15 epochs. Trainable components use AdamW with a learning rate of 10−410^{-4} and weight decay of 10−410^{-4} [29], gradient accumulation over 4 steps and a gradient-norm clipping threshold of 1. SOURCE-DEV evaluation is performed every 3 epochs and at the final epoch for checkpoint selection. Algorithm 1 summarizes training and deployment; evaluation uses the selected checkpoints from the five task folds.

Zero-Shot Inference

At deployment, the generator and shared basis remain fixed. MI-Hyper generates and caches the aggregation query and classifier parameters once per target text condition, then reuses them across cases. Target labels are not used to generate or update these parameters at deployment. Source-data use is documented separately for the evaluation setting.

The cached parameter count depends on the class vocabulary rather than bag length. Complete bags are processed in chunks with one global attention normalization (Supplementary Section S2).

Caching avoids regenerating parameters across cases; processing each bag still scales with its patch count.

Algorithm 1: MI-Hyper learning and inference
# Inputs: source FIT S, DEV D, descriptions,
# and query bags; encoders remain frozen
# Sample at most 2048 patches/training bag
# 1. Joint CE: task context + morphology text
W0, phi = initialize()
anchor = fit_ce(S, W0, phi, text=morphology,
                train=(W0, phi))
W0_star, phi_star = select_dev(anchor, D)
# 2. Extend generator; fix shared MIL basis
freeze(W0_star)
phi = expand_dual_text(phi_star)
objective = CE + 0.1*JS + 0.01*GATE
         + 0.1*PROXY
refined = fit_full(S, W0_star, phi,
                   loss=objective, train=phi)
phi_hat = select_dev(refined, D)
# 3. Generate from text; infer on all patches
theta = H(phi_hat, target_descriptions)
probs = [MIL_all(X, W0_star, theta)
         for X in target_bags]
# No target updates; DEV selects checkpoints

Experiments

Training details. We train five MI-Hyper models under the 112-group partition, using the SOURCE-FIT, SOURCE-DEV and target roles defined in Methods. We optimize parameters on SOURCE-FIT training cases and select checkpoints by task-average AUC on SOURCE-DEV validation cases. Both stages run for 15 epochs with the optimizer and patch-sampling settings in Methods.

Evaluation protocols. We evaluate text-conditioned MIL model construction on 308 dataset–endpoint tasks from 52 pathology datasets. The common query set contains 160,989 task–bag records and 896 task-specific classes. Because a case may support several endpoints, these records do not represent mutually independent WSIs or patients. Bags contain 10–145,183 stored patches, with a median of 1,866, and all tasks contribute to the overall statistics. Supplementary Figure S1 summarizes endpoint, anatomical and dataset coverage. Because mutation and staging tasks account for a large share of the collection, we report group-level results alongside the overall averages to distinguish coverage from performance within each group.

Figure S1. Composition of the evaluation tasks. (a) Task counts in 25 anatomical display groups formed by merging the registry’s 29 anatomical labels. (b) All 308 tasks grouped into 16 endpoint types. (c) All 52 pathology datasets, including 11 additional datasets listed individually. Counts are taken from the task registry and include every group. Anatomical icons are schematic.

For each task, we evaluate its original target-fold checkpoint against MI-Zero on the same query records, using all stored patches and keeping the generator and MIL basis fixed. Seven predefined pairs of text descriptions are used for each task, with a predictor generated and evaluated separately for each condition. Although target task IDs are held out, cases can recur in other source tasks. Matching patient identifiers or feature files across tasks identifies 100,573 query records in the eligible SOURCE-FIT pool and 4,873 in SOURCE-DEV; 55,543 have no recorded match. Pool membership does not establish that every case was sampled during optimization, and an unmatched record does not rule out unrecorded exposure. The evaluation therefore measures transfer to held-out task IDs across the complete query set, rather than generalization to an entirely unseen patient population.

The main text compares macro one-vs-rest AUC and balanced accuracy (BAcc); the complete task-level results additionally report macro-F1 (Supplementary Table S1). All metrics are percentages. We first evaluate each condition, average condition metrics within each task, and then weight the 308 tasks equally. MI-Zero uses 50 prompts at each of K=1,5,10,50,100K = 1, 5, 10, 50, 100, with Mean-K averaging all 250 condition metrics on the same query records as MI-Hyper. MI-Hyper uses all seven predefined text conditions, without choosing conditions or task-specific models from target labels. We compute percentage-point differences from unrounded scores; their signs and colors indicate direction, not statistical significance.

TaskNNCCMetricMI-Zero K=1K=1MI-Zero K=5K=5MI-Zero K=10K=10MI-Zero K=50K=50MI-Zero K=100K=100Mean KKMI-Hyper 7-condition mean
REG_dataset
REG_dataset/bladder_grade3482AUC88.9590.7091.0290.3189.5590.1190.39
BAcc64.2663.8463.7362.1460.3762.8750.69
F154.1253.4153.2650.7247.8151.8739.43
REG_dataset/bladder_invasion_depth8673AUC75.4079.3579.8377.2275.2677.4174.77
BAcc43.4144.8344.1841.0838.4042.3851.68
F139.6340.9540.3236.6633.2238.1547.33
REG_dataset/bladder_invasiveness8083AUC87.7691.4792.6294.1293.8891.9783.45
BAcc64.9866.2067.1568.8471.0567.6542.65
F159.2061.5662.2163.8364.3862.2437.06
REG_dataset/bladder_tumor_presence8672AUC53.6660.8463.9869.5670.6963.7528.24
BAcc51.4555.3657.0761.1361.3657.2731.10
F130.6530.2030.4131.3231.2330.7620.34
REG_dataset/bladder_tumor_type8675AUC78.4978.1677.7476.0374.6577.0179.18
BAcc52.7855.1255.6053.6950.5453.5530.88
F145.2845.4144.7340.3936.8842.5427.28
REG_dataset/breast_dcis_presence12282AUC30.4025.0223.9722.2621.9224.7132.97
BAcc38.7337.2237.6439.5440.4738.7239.70
F132.1527.5526.5025.6225.2127.4139.29
REG_dataset/breast_histologic_grade9153AUC66.6168.2868.5867.9966.6267.6264.35
BAcc49.2249.6950.2349.0346.0448.8443.58
F140.8040.1940.1239.5838.8539.9023.01
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KKMI-Hyper 7-condition mean
REG_dataset/breast_histologic_type16129AUC93.8095.0095.2094.7293.3794.4261.26
REG_dataset/breast_histologic_type16129BAcc42.6348.1248.6745.6542.5345.5221.30
REG_dataset/breast_histologic_type16129F144.8350.8651.6248.5444.9948.176.67
REG_dataset/breast_mitotic_score9153AUC58.3057.9057.1854.8352.6956.1861.22
REG_dataset/breast_mitotic_score9153BAcc35.4733.4931.3130.9032.7032.7736.71
REG_dataset/breast_mitotic_score9153F16.925.865.848.3511.577.717.61
REG_dataset/breast_nuclear_grade9153AUC70.9073.3973.5972.0269.7671.9380.20
REG_dataset/breast_nuclear_grade9153BAcc44.1945.2445.4046.2045.8445.3735.11
REG_dataset/breast_nuclear_grade9153F139.9040.6441.1543.3743.4641.7016.99
REG_dataset/breast_procedure_type19164AUC58.9960.3360.4159.8659.1159.7454.32
REG_dataset/breast_procedure_type19164BAcc32.3233.0833.7834.4632.9133.3126.55
REG_dataset/breast_procedure_type19164F129.0029.4029.5629.1927.5528.9414.40
REG_dataset/breast_tubule_formation9153AUC66.6069.7970.3170.7872.2769.9561.00
REG_dataset/breast_tubule_formation9153BAcc42.4347.5945.5046.6551.5046.7341.92
REG_dataset/breast_tubule_formation9153F134.0836.8536.5536.1434.8135.6920.89
REG_dataset/cervix_cin_grade4963AUC63.1968.2969.4069.5367.8567.6569.29
REG_dataset/cervix_cin_grade4963BAcc43.3045.0345.1544.6142.9944.2133.69
REG_dataset/cervix_cin_grade4963F143.5945.9345.9644.9442.9444.6823.95
REG_dataset/cervix_invasive_vs_preinvasive5782AUC91.8496.5197.1598.1698.2896.3992.72
REG_dataset/cervix_invasive_vs_preinvasive5782BAcc61.5961.2063.0569.7374.2565.9686.51
REG_dataset/cervix_invasive_vs_preinvasive5782F129.2628.4331.1440.6346.8135.2565.68
REG_dataset/cervix_procedure_type6132AUC43.5942.7843.2043.2544.2543.4247.47
REG_dataset/cervix_procedure_type6132BAcc46.1246.3946.0145.8346.4846.1648.45
REG_dataset/cervix_procedure_type6132F142.2841.3640.9141.7142.9941.8538.33
REG_dataset/cervix_sil_grade4962AUC70.4373.9874.6974.9472.3573.2876.69
REG_dataset/cervix_sil_grade4962BAcc55.8352.9352.1051.0050.8052.5351.46
REG_dataset/cervix_sil_grade4962F148.2341.0439.1236.6536.2340.2537.63
REG_dataset/colon_adenoma_dysplasia1912AUC87.8990.8791.9994.6795.6492.2186.25
REG_dataset/colon_adenoma_dysplasia1912BAcc78.7182.6184.1086.1488.1283.9479.05
REG_dataset/colon_adenoma_dysplasia1912F175.4880.3082.0385.4188.1582.2776.98
REG_dataset/colon_differentiation4983AUC73.4473.7373.5074.2774.1273.8164.19
REG_dataset/colon_differentiation4983BAcc62.4763.5565.2867.0965.4764.7737.29
REG_dataset/colon_differentiation4983F148.5948.1148.8749.7047.6648.589.98
REG_dataset/colon_histologic_type91510AUC91.5492.9493.3293.6393.3092.9578.56
REG_dataset/colon_histologic_type91510BAcc52.4156.2857.8658.1755.8056.1029.21
REG_dataset/colon_histologic_type91510F143.0146.1246.8545.6243.0944.9412.00
REG_dataset/colon_malignant_vs_benign9173AUC78.1481.2581.1580.3779.9980.1889.29
REG_dataset/colon_malignant_vs_benign9173BAcc46.2347.7746.9242.9941.8745.1672.36
REG_dataset/colon_malignant_vs_benign9173F141.4342.0941.5038.7838.2040.4070.09
REG_dataset/lung_histologic_type7533AUC89.9490.9491.3192.0592.2191.2993.75
REG_dataset/lung_histologic_type7533BAcc73.4874.5375.1574.4073.3774.1974.72
REG_dataset/lung_histologic_type7533F174.3575.1175.8275.5974.8475.1476.09
REG_dataset/lung_malignant_vs_benign8882AUC68.9370.2770.4769.4368.0069.4294.43
REG_dataset/lung_malignant_vs_benign8882BAcc63.3265.9066.0566.7765.8565.5886.67
REG_dataset/lung_malignant_vs_benign8882F153.0753.8553.7553.2152.1953.2178.71
REG_dataset/lung_small_cell_vs_nsclc7542AUC68.2471.3371.3571.6171.8470.8784.27
REG_dataset/lung_small_cell_vs_nsclc7542BAcc56.2756.5055.7353.3352.7354.9171.94
REG_dataset/lung_small_cell_vs_nsclc7542F155.2154.7053.1748.7947.6751.9168.53
REG_dataset/multi_organ_malignancy_detection74033AUC61.9963.0363.1961.9760.6862.1765.26
REG_dataset/multi_organ_malignancy_detection74033BAcc37.0736.1534.9931.7529.9933.9943.12
REG_dataset/multi_organ_malignancy_detection74033F130.6830.2429.7128.1227.0029.1544.95
REG_dataset/multi_organ_organ_classification84637AUC97.0398.1198.3198.5798.6198.1263.01
REG_dataset/multi_organ_organ_classification84637BAcc67.0870.6371.9675.5876.9772.4427.00
REG_dataset/multi_organ_organ_classification84637F165.2669.4171.0375.3177.0271.6122.46
REG_dataset/multi_organ_procedure_classification84619AUC86.2387.7388.1388.6888.8487.9267.80
REG_dataset/multi_organ_procedure_classification84619BAcc47.3750.4551.2651.6251.0150.3418.39
REG_dataset/multi_organ_procedure_classification84619F137.4640.5941.4542.7242.8841.0210.60
REG_dataset/prostate_gleason_score13505AUC63.5366.7868.6867.9466.8266.7552.03
REG_dataset/prostate_gleason_score13505BAcc26.6427.7128.3429.9829.6128.4627.10
REG_dataset/prostate_gleason_score13505F116.7116.9116.7116.6716.6416.7317.21
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KKMI-Hyper 7-condition mean
REG_dataset/prostate_grade_group13505AUC52.9852.9053.7055.9656.4954.4168.30
REG_dataset/prostate_grade_group13505BAcc18.8117.4216.3215.7616.5016.9733.75
REG_dataset/prostate_grade_group13505F116.3513.6012.5611.1410.1512.7623.39
REG_dataset/prostate_primary_gleason13483AUC64.0468.9569.9368.7068.2867.9873.81
REG_dataset/prostate_primary_gleason13483BAcc40.8743.5844.8542.2141.5442.6157.77
REG_dataset/prostate_primary_gleason13483F126.7528.8130.0030.7131.8229.6235.99
REG_dataset/prostate_secondary_gleason13483AUC59.6662.6163.0762.6661.9862.0073.18
REG_dataset/prostate_secondary_gleason13483BAcc36.2337.9939.6239.7539.9238.7055.75
REG_dataset/prostate_secondary_gleason13483F125.7225.6326.6627.9328.6326.9140.34
REG_dataset/prostate_tumor_presence17462AUC50.3651.4652.7356.1558.2653.7992.02
REG_dataset/prostate_tumor_presence17462BAcc50.5651.9453.1855.8756.7653.6659.65
REG_dataset/prostate_tumor_presence17462F143.8143.8644.2643.2541.5443.3437.73
REG_dataset/stomach_adenoma_dysplasia4202AUC63.8769.4271.8073.7870.5969.8986.10
REG_dataset/stomach_adenoma_dysplasia4202BAcc50.9650.7250.7453.1355.1552.1460.38
REG_dataset/stomach_adenoma_dysplasia4202F18.677.317.4212.5718.3710.8756.78
REG_dataset/stomach_differentiation6153AUC81.2482.4082.2880.4878.9781.0759.21
REG_dataset/stomach_differentiation6153BAcc56.0557.7158.4460.3159.6458.4336.31
REG_dataset/stomach_differentiation6153F152.4954.1555.1356.5654.2154.5124.46
REG_dataset/stomach_histologic_type14528AUC89.1590.3990.8991.4691.1390.6079.73
REG_dataset/stomach_histologic_type14528BAcc60.6964.0864.2661.4760.5162.2037.27
REG_dataset/stomach_histologic_type14528F152.2057.5658.4156.7356.0556.1923.96
REG_dataset/stomach_intestinal_metaplasia2552AUC61.8764.3765.2263.8862.4663.5676.37
REG_dataset/stomach_intestinal_metaplasia2552BAcc57.9457.7057.7757.8657.8657.8351.58
REG_dataset/stomach_intestinal_metaplasia2552F149.3848.3848.3248.5448.6148.6539.29
REG_dataset/stomach_malignant_vs_benign14623AUC76.4582.0783.7185.7184.9482.5889.00
REG_dataset/stomach_malignant_vs_benign14623BAcc55.5158.9059.5060.0159.3558.6572.06
REG_dataset/stomach_malignant_vs_benign14623F150.3253.0753.6353.7952.9152.7565.15
TCGA_ACC
TCGA_ACC/molecular_subtype_cna522AUC65.8167.2467.6464.4163.2065.6631.98
TCGA_ACC/molecular_subtype_cna522BAcc60.1962.7063.4365.6366.0163.5945.33
TCGA_ACC/molecular_subtype_cna522F159.3361.8762.7865.6866.2563.1838.91
TCGA_ACC/molecular_subtype_dnameth543AUC48.6355.1656.9657.7357.8455.2662.06
TCGA_ACC/molecular_subtype_dnameth543BAcc33.5740.6242.4842.3241.4740.0941.79
TCGA_ACC/molecular_subtype_dnameth543F128.6632.3433.9833.3033.0232.2636.98
TCGA_ACC/molecular_subtype_mrna523AUC54.7051.4851.6950.9850.3551.8468.84
TCGA_ACC/molecular_subtype_mrna523BAcc33.7028.3326.9226.1627.3228.4951.79
TCGA_ACC/molecular_subtype_mrna523F132.4026.9425.4124.5525.6426.9946.27
TCGA_ACC/molecular_subtype_selected543AUC49.1644.2744.0643.5243.4744.9060.58
TCGA_ACC/molecular_subtype_selected543BAcc32.9928.3329.6931.5832.2730.9741.63
TCGA_ACC/molecular_subtype_selected543F124.1618.4919.7420.3321.3020.8036.23
TCGA_BLCA
TCGA_BLCA/ARID1A_mutation3862AUC49.3250.1250.3650.8450.7850.2951.37
TCGA_BLCA/ARID1A_mutation3862BAcc50.0750.1550.7150.9850.8750.5552.12
TCGA_BLCA/ARID1A_mutation3862F137.0436.3636.7736.7736.4436.6848.18
TCGA_BLCA/BAP1_mutation3862AUC50.8954.7853.2250.0749.3651.6759.47
TCGA_BLCA/BAP1_mutation3862BAcc49.2349.2348.7848.9949.1149.0752.71
TCGA_BLCA/BAP1_mutation3862F139.6238.2537.7737.2637.1238.0119.69
TCGA_BLCA/CDKN2A_mutation3862AUC48.3249.8051.2253.2253.9751.3052.49
TCGA_BLCA/CDKN2A_mutation3862BAcc46.1947.2748.1449.2749.9648.1750.26
TCGA_BLCA/CDKN2A_mutation3862F142.6943.9744.7245.9546.3144.7330.89
TCGA_BLCA/ERBB2_mutation3862AUC47.2747.5147.5145.6945.7846.7652.03
TCGA_BLCA/ERBB2_mutation3862BAcc48.4248.9149.2448.2048.2948.6150.33
TCGA_BLCA/ERBB2_mutation3862F146.3046.7446.6845.5545.5046.1542.76
TCGA_BLCA/MET_mutation3862AUC51.1350.6250.1449.6849.7850.2745.84
TCGA_BLCA/MET_mutation3862BAcc50.1749.5450.4050.9850.9650.4148.58
TCGA_BLCA/MET_mutation3862F136.7135.9036.3136.4836.5536.3934.53
TCGA_BLCA/RB1_mutation3862AUC45.7244.8044.5843.8443.8144.5561.92
TCGA_BLCA/RB1_mutation3862BAcc49.9950.1750.2350.2150.4650.2157.28
TCGA_BLCA/RB1_mutation3862F147.3147.1347.0746.8947.1047.1049.77
TaskNNCCMetricMI-Zero K=1K=1MI-Zero K=5K=5MI-Zero K=10K=10MI-Zero K=50K=50MI-Zero K=100K=100Mean KKMI-Hyper 7-condition mean
TCGA_BLCA/SETD2_mutation3862AUC43.6944.7244.7045.2745.6844.8151.87
BAcc46.4646.6746.7147.9047.8147.1149.69
F135.2735.2135.3836.2736.4435.7143.93
TCGA_BLCA/TP53_mutation3862AUC42.4242.9142.6342.1941.9542.4259.60
BAcc47.4947.4347.2347.4247.3547.3854.82
F140.7038.9538.5538.7038.7039.1253.56
TCGA_BLCA/ajcc_pathologic_m1862AUC55.5955.3854.4656.0856.2755.5670.06
BAcc52.0953.7553.6053.8754.0453.4759.94
F132.9732.0531.1330.2829.9031.2635.33
TCGA_BLCA/ajcc_pathologic_n3383AUC51.2150.8151.0250.7950.3050.8364.05
BAcc33.9633.9033.9733.9433.3533.8342.54
F128.2826.0025.4724.2823.6525.5331.49
TCGA_BLCA/ajcc_pathologic_stage3823AUC57.5259.2559.7160.9660.9159.6766.08
BAcc37.7437.9538.1138.2938.5638.1344.91
F133.9732.8132.5532.1932.4632.8039.99
TCGA_BLCA/ajcc_pathologic_t3543AUC55.6856.6556.7856.7457.0256.5759.94
BAcc38.9239.5039.7239.6839.8439.5338.04
F135.7736.0736.3136.4636.6436.2527.85
TCGA_BRCA
TCGA_BRCA/BAP1_mutation10552AUC48.1544.9046.3347.7648.0647.0453.27
BAcc50.3548.1548.4149.1249.0849.0251.11
F143.6243.9043.9443.8443.6443.7934.05
TCGA_BRCA/ERBB2_mutation10552AUC47.5746.5545.8945.8746.1146.4040.49
BAcc49.5150.2050.5450.8050.4050.2947.19
F133.5233.1633.1232.9932.8833.1340.88
TCGA_BRCA/MET_mutation10552AUC50.6157.0958.3058.9258.8856.7638.67
BAcc49.4952.7252.9654.2154.1152.7043.75
F138.1538.2138.3438.7838.7438.4438.39
TCGA_BRCA/PIK3CA_mutation10552AUC49.8750.5550.6850.6050.5850.4646.20
BAcc50.4950.5050.4950.5550.4450.4948.68
F147.3046.4546.3146.2946.1946.5146.37
TCGA_BRCA/RB1_mutation10552AUC52.8152.5752.7852.9052.4552.7046.53
BAcc49.7849.3449.5549.5749.6349.5747.74
F147.6247.5847.7547.8147.7747.7034.13
TCGA_BRCA/ajcc_pathologic_m8972AUC57.4257.6357.0956.5856.5857.0649.79
BAcc53.0752.2450.6850.0349.7351.1549.79
F134.2731.9630.2829.0428.7530.8615.75
TCGA_BRCA/ajcc_pathologic_n10364AUC50.4750.0150.1850.2750.3750.2656.15
BAcc24.8224.9725.0024.9524.9824.9428.08
F117.1415.7615.4915.0114.9815.679.86
TCGA_BRCA/ajcc_pathologic_stage10324AUC52.2452.2551.9851.9051.9552.0650.97
BAcc28.5127.2726.5326.0126.0626.8829.11
F120.4820.4920.4520.4520.4120.4610.74
TCGA_BRCA/ajcc_pathologic_t10534AUC48.8549.5649.5150.1250.4749.7052.76
BAcc22.5922.4422.2922.2322.2322.3528.80
F116.4514.9614.7114.5114.5615.0411.98
TCGA_BRCA/molecular_subtype_mrna9545AUC61.1462.5662.9463.3863.3062.6658.00
BAcc21.4521.4121.4921.3221.3521.4026.15
F110.8810.3710.4010.1210.1110.3712.36
TCGA_BRCA/molecular_subtype_selected9545AUC61.0262.0362.2362.5462.6162.0957.71
BAcc25.0825.2225.4725.3225.3725.2926.54
F115.2314.8714.9915.1015.0115.0413.49
TCGA_BRCA/primary_diagnosis8852AUC92.7593.5093.7093.9293.8093.5479.54
BAcc85.6486.2286.4585.6985.2485.8562.54
F183.7485.2685.7485.9585.9785.3344.56
TCGA_CESC
TCGA_CESC/ajcc_pathologic_m1202AUC71.6870.4069.3868.4269.7569.9366.96
BAcc60.0156.7956.7555.9557.0557.3159.42
F134.8132.0831.6329.2129.2231.3951.70
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KKMI-Hyper 7-condition mean
TCGA_CESC/ajcc_pathologic_n1742AUC55.8055.1954.4354.5054.6954.9251.71
TCGA_CESC/ajcc_pathologic_n1742BAcc54.1553.4753.4753.3253.5853.6049.58
TCGA_CESC/ajcc_pathologic_n1742F150.4849.1648.8347.5447.6748.7448.03
TCGA_CESC/ajcc_pathologic_t2214AUC55.1756.3256.4357.1457.1456.4454.15
TCGA_CESC/ajcc_pathologic_t2214BAcc27.4126.6826.4926.9427.0026.9027.30
TCGA_CESC/ajcc_pathologic_t2214F117.8817.2416.9817.2817.1217.3021.19
TCGA_CESC/tumor_grade2373AUC59.9364.0264.6265.7366.0764.0766.32
TCGA_CESC/tumor_grade2373BAcc36.2236.4736.3936.8336.9536.5745.46
TCGA_CESC/tumor_grade2373F129.1227.7527.2827.6927.8627.9435.35
TCGA_CHOL/ajcc_pathologic_stage292AUC60.6657.0056.4057.6157.6257.8645.64
TCGA_CHOL/ajcc_pathologic_stage292BAcc54.0154.2854.1353.3053.3953.8246.13
TCGA_CHOL/ajcc_pathologic_stage292F140.6339.3639.3638.1338.1139.1244.27
TCGA_CHOL/ajcc_pathologic_t322AUC37.8842.7443.2443.5044.3142.3347.37
TCGA_CHOL/ajcc_pathologic_t322BAcc44.3648.5350.1350.5850.5348.8345.14
TCGA_CHOL/ajcc_pathologic_t322F136.6639.3941.1840.8440.6939.7544.50
TCGA_CHOL/tumor_grade362AUC33.9636.3336.4036.1136.3335.8359.97
TCGA_CHOL/tumor_grade362BAcc35.5838.7838.5037.5737.5537.6051.15
TCGA_CHOL/tumor_grade362F134.6837.1936.7435.7235.8036.0350.41
TCGA_COAD/ALK_mutation4342AUC45.6147.9247.8848.0647.9347.4852.56
TCGA_COAD/ALK_mutation4342BAcc47.7648.8548.3948.3348.5848.3849.27
TCGA_COAD/ALK_mutation4342F144.7046.0945.3644.8444.9445.1937.28
TCGA_COAD/APC_mutation4342AUC48.2146.9546.6046.5546.8147.0349.76
TCGA_COAD/APC_mutation4342BAcc49.0849.7550.0449.9749.9649.7648.81
TCGA_COAD/APC_mutation4342F134.2232.6232.6332.3732.6332.8943.15
TCGA_COAD/ATRX_mutation4342AUC43.0842.0942.3942.1642.0242.3565.81
TCGA_COAD/ATRX_mutation4342BAcc46.5745.4245.9246.0245.8545.9662.86
TCGA_COAD/ATRX_mutation4342F127.9126.8327.1827.2327.1527.2650.15
TCGA_COAD/BRAF_mutation4342AUC44.1644.7544.8943.9643.8144.3163.77
TCGA_COAD/BRAF_mutation4342BAcc46.3346.1746.5046.7746.8146.5158.04
TCGA_COAD/BRAF_mutation4342F136.5134.9234.5434.0733.8534.7848.16
TCGA_COAD/CTNNB1_mutation4342AUC44.2943.3643.0443.2743.5943.5162.28
TCGA_COAD/CTNNB1_mutation4342BAcc46.4046.5346.5245.9546.3946.3657.95
TCGA_COAD/CTNNB1_mutation4342F137.2836.8836.2034.2633.4935.6251.23
TCGA_COAD/FBXW7_mutation4342AUC48.1649.0449.0148.6948.3848.6663.14
TCGA_COAD/FBXW7_mutation4342BAcc49.6849.7449.4949.1848.8549.3960.49
TCGA_COAD/FBXW7_mutation4342F139.4338.3738.0737.4137.0338.0654.23
TCGA_COAD/IDH2_mutation4342AUC48.9546.1345.5444.0543.8745.7162.67
TCGA_COAD/IDH2_mutation4342BAcc47.6947.9248.3548.6548.6848.2658.14
TCGA_COAD/IDH2_mutation4342F133.7433.7033.7133.6433.6033.6838.75
TCGA_COAD/KRAS_mutation4342AUC49.5548.6748.5948.6148.7548.8449.12
TCGA_COAD/KRAS_mutation4342BAcc49.4048.8649.3749.3449.4549.2850.01
TCGA_COAD/KRAS_mutation4342F142.3339.8540.1439.7039.9240.3949.70
TCGA_COAD/MET_mutation4342AUC41.4539.4040.0039.5639.1739.9161.95
TCGA_COAD/MET_mutation4342BAcc44.3643.0243.5444.0643.1643.6359.13
TCGA_COAD/MET_mutation4342F127.5124.3223.8423.3122.9624.3944.01
TCGA_COAD/PIK3CA_mutation4342AUC47.9748.6148.2548.1848.1448.2356.56
TCGA_COAD/PIK3CA_mutation4342BAcc48.9248.6648.7148.9848.9048.8452.99
TCGA_COAD/PIK3CA_mutation4342F140.0937.7337.4337.1436.9037.8651.98
TCGA_COAD/SMAD4_mutation4342AUC42.9643.9743.9944.3244.7243.9958.47
TCGA_COAD/SMAD4_mutation4342BAcc46.1747.6847.2847.3447.6947.2357.10
TCGA_COAD/SMAD4_mutation4342F131.2230.4329.9429.6829.9030.2443.51
TCGA_COAD/ajcc_pathologic_m3802AUC56.1458.4358.0758.9058.9758.1068.45
TCGA_COAD/ajcc_pathologic_m3802BAcc52.9354.2854.3454.4854.5254.1163.53
TCGA_COAD/ajcc_pathologic_m3802F143.5443.4343.3742.8142.6443.1657.49
TCGA_COAD/ajcc_pathologic_n4333AUC51.9252.4352.3053.4553.7452.7761.93
TCGA_COAD/ajcc_pathologic_n4333BAcc34.6233.8033.9934.3234.1934.1842.33
TCGA_COAD/ajcc_pathologic_n4333F123.1120.7620.4720.5120.5721.0938.46
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KKMI-Hyper 7-condition mean
TCGA_COAD/ajcc_pathologic_stage4224AUC56.6558.2958.7759.0059.2058.3858.88
TCGA_COAD/ajcc_pathologic_stage4224BAcc27.9928.9028.9129.3129.6228.9431.79
TCGA_COAD/ajcc_pathologic_stage4224F125.0825.2625.1225.4625.7625.3426.47
TCGA_COAD/ajcc_pathologic_t4324AUC54.5354.0354.4355.9156.8355.1455.41
TCGA_COAD/ajcc_pathologic_t4324BAcc27.1925.8726.2626.7127.5026.7132.40
TCGA_COAD/ajcc_pathologic_t4324F117.5616.4016.5916.5816.5816.7415.60
TCGA_COAD/molecular_subtype_other3183AUC49.9948.9848.4747.2446.7048.2752.46
TCGA_COAD/molecular_subtype_other3183BAcc32.9832.7933.7833.7133.3833.3337.55
TCGA_COAD/molecular_subtype_other3183F133.9233.7634.6634.6834.4134.2936.20
TCGA_COAD/molecular_subtype_selected3183AUC50.2548.5447.8246.9746.5948.0452.51
TCGA_COAD/molecular_subtype_selected3183BAcc31.7630.9631.0730.7630.4431.0037.23
TCGA_COAD/molecular_subtype_selected3183F133.5333.1033.2933.1932.9133.2036.13
TCGA_COAD/primary_diagnosis4202AUC88.3088.0187.8087.0186.4787.5265.62
TCGA_COAD/primary_diagnosis4202BAcc75.4973.8873.7472.3870.8973.2859.43
TCGA_COAD/primary_diagnosis4202F175.4774.3774.6873.5572.1474.0458.20
TCGA_ESCA/ajcc_pathologic_n1303AUC46.3544.6443.5742.1341.5643.6547.28
TCGA_ESCA/ajcc_pathologic_n1303BAcc30.8430.2829.5129.3429.0529.8131.24
TCGA_ESCA/ajcc_pathologic_n1303F121.7920.2519.3919.4519.3920.0526.57
TCGA_ESCA/ajcc_pathologic_stage1303AUC55.7157.5757.0957.3057.2056.9759.70
TCGA_ESCA/ajcc_pathologic_stage1303BAcc36.8737.2437.5337.6537.7737.4145.20
TCGA_ESCA/ajcc_pathologic_stage1303F127.2527.3627.7329.0229.6628.2032.68
TCGA_ESCA/ajcc_pathologic_t1343AUC66.3368.5369.5771.0271.5869.4174.93
TCGA_ESCA/ajcc_pathologic_t1343BAcc46.0350.5052.9955.5357.4652.5057.15
TCGA_ESCA/ajcc_pathologic_t1343F143.7745.8547.5847.8448.7546.7653.36
TCGA_ESCA/molecular_subtype_other1412AUC76.2477.7578.1976.8575.8076.9694.63
TCGA_ESCA/molecular_subtype_other1412BAcc60.6261.7862.9263.3462.0962.1584.25
TCGA_ESCA/molecular_subtype_other1412F157.5259.2260.8761.3059.2259.6285.44
TCGA_ESCA/molecular_subtype_selected1412AUC78.4981.9982.9483.4183.0481.9894.45
TCGA_ESCA/molecular_subtype_selected1412BAcc59.0860.2261.1560.6458.6059.9484.03
TCGA_ESCA/molecular_subtype_selected1412F154.7756.4457.8857.3954.2356.1485.25
TCGA_ESCA/primary_diagnosis1472AUC99.6699.7799.7999.8699.8899.7999.31
TCGA_ESCA/primary_diagnosis1472BAcc96.9197.2997.3597.0297.0997.1395.64
TCGA_ESCA/primary_diagnosis1472F196.5496.9797.0496.6696.7496.7995.75
TCGA_ESCA/tumor_grade1393AUC52.9153.9154.1053.6553.5053.6152.61
TCGA_ESCA/tumor_grade1393BAcc32.7532.6333.2033.6533.7233.1932.99
TCGA_ESCA/tumor_grade1393F122.4022.7224.0725.4825.8724.1125.48
TCGA_GBM/EGFR_mutation3892AUC46.6347.4447.4747.3347.6947.3142.39
TCGA_GBM/EGFR_mutation3892BAcc48.7850.3950.1849.2049.2149.5546.50
TCGA_GBM/EGFR_mutation3892F141.7841.7041.4341.1241.4041.4823.74
TCGA_HNSC/CDKN2A_mutation4502AUC50.4049.6149.9550.4350.2950.1356.71
TCGA_HNSC/CDKN2A_mutation4502BAcc49.3849.5049.5249.6549.8349.5853.26
TCGA_HNSC/CDKN2A_mutation4502F147.8447.2747.2247.1647.3247.3634.52
TCGA_HNSC/TP53_mutation4502AUC45.7345.2445.1144.5343.8844.9046.82
TCGA_HNSC/TP53_mutation4502BAcc48.5848.8148.8848.4348.2348.5948.38
TCGA_HNSC/TP53_mutation4502F138.0936.8236.4635.3134.9336.3243.59
TCGA_HNSC/ajcc_pathologic_n3663AUC51.1352.0852.3351.9351.6951.8356.47
TCGA_HNSC/ajcc_pathologic_n3663BAcc34.1734.5534.5134.2633.9334.2834.28
TCGA_HNSC/ajcc_pathologic_n3663F129.8428.2327.7026.6025.9327.6625.86
TCGA_HNSC/ajcc_pathologic_stage4004AUC53.4253.0752.9953.8853.9853.4757.37
TCGA_HNSC/ajcc_pathologic_stage4004BAcc26.7225.8425.5725.2925.4225.7726.98
TCGA_HNSC/ajcc_pathologic_stage4004F115.9014.1513.6412.9113.0713.9316.74
TCGA_HNSC/ajcc_pathologic_t4084AUC52.1053.2153.4853.6253.8153.2555.91
TCGA_HNSC/ajcc_pathologic_t4084BAcc26.0725.5925.3425.0825.1525.4526.21
TCGA_HNSC/ajcc_pathologic_t4084F116.7215.1814.4313.8613.8314.8120.32
TCGA_HNSC/molecular_subtype_dnameth2224AUC50.5551.0151.4752.1452.1751.4745.58
TCGA_HNSC/molecular_subtype_dnameth2224BAcc23.1122.6421.9222.8824.0122.9121.54
TCGA_HNSC/molecular_subtype_dnameth2224F114.2413.0111.9510.3810.0011.9115.81
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KKMI-Hyper 7-condition mean
TCGA_HNSC/molecular_subtype_mrna2224AUC51.3552.0452.4853.0353.3752.4555.27
TCGA_HNSC/molecular_subtype_mrna2224BAcc24.7224.1824.0424.6123.2124.1525.53
TCGA_HNSC/molecular_subtype_mrna2224F120.2919.1818.8818.2416.1218.5418.62
TCGA_HNSC/molecular_subtype_selected2224AUC48.8448.3248.2148.0847.6248.2154.97
TCGA_HNSC/molecular_subtype_selected2224BAcc23.6725.3924.6623.9223.1224.1525.83
TCGA_HNSC/molecular_subtype_selected2224F121.2421.9921.1420.2919.5420.8418.98
TCGA_HNSC/tumor_grade4283AUC52.0054.3154.3455.2055.1054.1967.22
TCGA_HNSC/tumor_grade4283BAcc32.4032.7432.8233.1033.4832.9148.51
TCGA_HNSC/tumor_grade4283F114.6514.5714.7614.6015.0614.7340.62
TCGA_KICH/ajcc_pathologic_stage1023AUC54.7455.3055.3754.4654.7954.9353.59
TCGA_KICH/ajcc_pathologic_stage1023BAcc34.1732.9933.1433.2733.2733.3736.32
TCGA_KICH/ajcc_pathologic_stage1023F124.8420.7820.3919.8519.6421.1027.62
TCGA_KICH/ajcc_pathologic_t1073AUC58.4957.4957.7256.8656.1157.3358.78
TCGA_KICH/ajcc_pathologic_t1073BAcc39.2537.3136.3236.0635.8836.9639.55
TCGA_KICH/ajcc_pathologic_t1073F135.7932.6831.0629.9929.6431.8334.19
TCGA_KIRC/BAP1_mutation5132AUC44.5545.4544.8144.5744.3544.7560.67
TCGA_KIRC/BAP1_mutation5132BAcc48.7749.1948.7949.0549.0748.9755.56
TCGA_KIRC/BAP1_mutation5132F126.8325.6125.2324.7724.6525.4230.40
TCGA_KIRC/PBRM1_mutation5132AUC53.1552.3652.2252.2452.2952.4549.24
TCGA_KIRC/PBRM1_mutation5132BAcc50.3650.2350.2950.2350.2550.2749.43
TCGA_KIRC/PBRM1_mutation5132F147.4146.5646.5246.3646.2546.6244.69
TCGA_KIRC/SETD2_mutation5132AUC53.8051.8851.2450.4650.2751.5363.67
TCGA_KIRC/SETD2_mutation5132BAcc50.7849.5649.2348.8948.9949.4952.32
TCGA_KIRC/SETD2_mutation5132F137.3634.9834.3233.4833.2834.6851.20
TCGA_KIRC/VHL_mutation5132AUC48.0848.6248.7648.7848.3048.5148.33
TCGA_KIRC/VHL_mutation5132BAcc48.7348.1948.1548.0947.9648.2247.91
TCGA_KIRC/VHL_mutation5132F143.6741.1240.7640.9240.9941.4945.38
TCGA_KIRC/ajcc_pathologic_m4832AUC55.3157.1356.7355.6154.4755.8536.89
TCGA_KIRC/ajcc_pathologic_m4832BAcc49.4949.3849.6949.7249.8849.6344.61
TCGA_KIRC/ajcc_pathologic_m4832F143.2842.3342.6142.4042.4942.6231.30
TCGA_KIRC/ajcc_pathologic_n2482AUC71.9968.0867.1067.3067.4968.3968.93
TCGA_KIRC/ajcc_pathologic_n2482BAcc54.9754.1353.5853.5053.4453.9264.60
TCGA_KIRC/ajcc_pathologic_n2482F148.8347.9347.6447.2547.0547.7448.92
TCGA_KIRC/ajcc_pathologic_stage5104AUC52.7854.0554.1654.3054.2353.9059.19
TCGA_KIRC/ajcc_pathologic_stage5104BAcc25.0325.4925.8525.7625.7225.5727.27
TCGA_KIRC/ajcc_pathologic_stage5104F116.3815.9716.1015.9615.8716.0623.12
TCGA_KIRC/ajcc_pathologic_t5134AUC60.6962.5962.9463.7263.7862.7565.82
TCGA_KIRC/ajcc_pathologic_t5134BAcc30.5129.6830.0030.3630.5830.2238.62
TCGA_KIRC/ajcc_pathologic_t5134F124.9623.6923.9324.1224.2424.1823.31
TCGA_KIRC/tumor_grade5054AUC64.1667.1267.9367.6967.4366.8768.60
TCGA_KIRC/tumor_grade5054BAcc27.4026.1825.9125.5025.2926.0641.60
TCGA_KIRC/tumor_grade5054F119.2617.8117.5117.3017.1917.8122.24
TCGA_KIRP/BAP1_mutation2742AUC49.6948.9048.3947.4947.4448.3847.70
TCGA_KIRP/BAP1_mutation2742BAcc50.2249.9448.8648.0848.5149.1247.47
TCGA_KIRP/BAP1_mutation2742F125.4423.2322.8322.5622.4723.3123.22
TCGA_KIRP/MET_mutation2742AUC44.9943.6342.8742.8142.5643.3745.11
TCGA_KIRP/MET_mutation2742BAcc47.7447.6346.6746.8047.3247.2347.28
TCGA_KIRP/MET_mutation2742F124.5222.1821.4721.4021.6622.2517.21
TCGA_KIRP/ajcc_pathologic_n652AUC68.1772.3073.9574.6474.4872.7160.78
TCGA_KIRP/ajcc_pathologic_n652BAcc62.4663.5264.1162.0461.3462.6957.26
TCGA_KIRP/ajcc_pathologic_n652F155.8056.4657.0254.6453.7455.5354.34
TCGA_KIRP/ajcc_pathologic_stage2454AUC61.1564.0164.5163.8363.5263.4060.88
TCGA_KIRP/ajcc_pathologic_stage2454BAcc33.1732.9233.2331.8331.5632.5434.59
TCGA_KIRP/ajcc_pathologic_stage2454F125.0523.7123.6222.4322.3623.4425.71
TCGA_KIRP/ajcc_pathologic_t2713AUC62.8663.5163.8264.1164.3463.7365.29
TCGA_KIRP/ajcc_pathologic_t2713BAcc42.2342.4142.5843.0343.0442.6642.39
TCGA_KIRP/ajcc_pathologic_t2713F139.0639.2439.3740.6040.9339.8439.40
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KKMI-Hyper 7-condition mean
TCGA_KIRP/molecular_subtype_cna1473AUC56.2857.2257.3457.1457.0557.0145.37
BAcc31.5232.6433.2533.4633.6032.8931.12
F124.5625.0025.2125.1225.1325.0015.69
TCGA_LGG
TCGA_LGG/ATRX_mutation4912AUC55.8656.1556.9457.4257.5956.7942.48
BAcc52.2251.5751.7352.0952.1551.9544.92
F143.7641.5841.5142.0142.0742.1841.32
TCGA_LGG/IDH1_mutation4912AUC56.7859.3559.8161.0561.2859.6537.02
BAcc51.5051.2651.4351.5651.6851.4947.86
F138.2336.0535.9735.7235.8436.3619.57
TCGA_LGG/IDH2_mutation4912AUC50.5546.3347.4545.9845.3447.1358.76
BAcc50.4149.2449.7349.3249.2449.5954.40
F129.8228.7628.8128.9229.0929.0826.49
TCGA_LGG/NF1_mutation4912AUC50.3852.7253.7754.0053.8452.9433.46
BAcc50.7650.5450.3850.3550.3150.4738.98
F128.5527.4227.2427.0126.8727.4238.54
TCGA_LGG/TP53_mutation4912AUC48.7149.2749.5350.5650.8749.7939.18
BAcc49.1549.3149.1549.4349.5649.3248.19
F141.9741.2540.8940.9441.0041.2136.07
TCGA_LGG/molecular_subtype_other4886AUC52.3753.3253.5854.1154.1153.5049.64
BAcc15.6115.2715.0915.3015.4115.3417.05
F19.228.998.869.059.169.069.88
TCGA_LGG/molecular_subtype_selected4886AUC50.5050.7351.0651.7851.9551.2149.77
BAcc13.5812.3611.9411.6911.3812.1917.15
F19.728.498.227.907.738.419.88
TCGA_LGG/tumor_grade4892AUC69.4573.0173.9774.6474.6073.1363.26
BAcc53.7052.1252.1751.9551.9452.3857.28
F142.1238.6238.2737.6037.5638.8352.70
TCGA_LIHC
TCGA_LIHC/BAP1_mutation3652AUC52.6852.2052.3451.8051.7252.1545.79
BAcc48.9348.4848.5848.7548.8348.7147.86
F124.7923.3223.1123.0123.2023.4940.57
TCGA_LIHC/CTNNB1_mutation3652AUC52.0050.7450.0349.4950.0450.4650.22
BAcc51.3851.2351.1850.7050.8651.0748.24
F137.3935.6335.2334.4434.5935.4647.26
TCGA_LIHC/ajcc_pathologic_stage3373AUC53.7053.2353.0052.6952.7453.0757.04
BAcc35.8935.8936.1035.2835.1235.6537.34
F127.4526.3226.4325.3625.0326.1234.15
TCGA_LIHC/ajcc_pathologic_t3624AUC58.8759.0658.0357.0856.9858.0056.72
BAcc31.1130.9030.3230.0430.3630.5526.29
F125.0725.0224.8824.4024.5724.7919.19
TCGA_LIHC/tumor_grade3604AUC54.6254.5555.5458.7860.0956.7163.28
BAcc26.7425.1025.3929.9231.8227.7934.67
F122.4020.5820.0921.4421.8421.2724.28
TCGA_LUAD
TCGA_LUAD/ALK_mutation4682AUC46.3545.8246.3546.3945.4246.0738.85
BAcc47.5648.4147.4847.7847.6547.7844.61
F146.0847.3646.8547.1547.1546.9225.51
TCGA_LUAD/CDKN2A_mutation4682AUC44.0944.8244.2045.7346.0144.9758.14
BAcc47.7647.6547.0647.7848.4647.7454.06
F140.7141.0540.8041.2441.4541.0541.85
TCGA_LUAD/EGFR_mutation4682AUC57.9659.3859.9060.7560.6859.7345.35
BAcc55.1654.9455.2355.3755.4055.2246.74
F146.1545.2445.4746.0146.4545.8732.78
TCGA_LUAD/KRAS_mutation4682AUC49.4348.2848.8849.0049.0848.9341.31
BAcc49.3748.2648.4148.5448.9148.7047.15
F144.5442.9542.9643.4844.0943.6145.07
TCGA_LUAD/SETD2_mutation4682AUC53.7952.1051.8450.2149.8851.5652.58
BAcc50.0749.9050.0749.8049.6349.8952.11
F128.2628.6529.0430.3131.0229.4650.08
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KKMI-Hyper 7-condition mean
TCGA_LUAD/SMAD4_mutation4682AUC58.3152.9751.7051.8351.8853.3438.08
BAcc53.2251.7250.8149.2648.9350.7948.23
F136.2634.8834.3634.3034.6534.8946.90
TCGA_LUAD/ajcc_pathologic_m3362AUC55.9859.3659.3558.6758.8958.4554.00
BAcc55.0355.7655.3255.3255.1055.3154.83
F143.0042.4641.4739.1838.2440.8751.00
TCGA_LUAD/ajcc_pathologic_n4553AUC48.6447.0446.7846.8446.9747.2651.79
BAcc33.5433.1433.1733.1433.1633.2335.93
F119.3216.8716.9316.8216.9217.3728.29
TCGA_LUAD/ajcc_pathologic_stage4604AUC54.4654.2153.8553.6053.7953.9855.72
BAcc26.8925.9326.0825.9726.3626.2529.67
F119.2318.1018.2418.3218.5018.4825.75
TCGA_LUAD/ajcc_pathologic_t4654AUC54.0354.2654.4554.4453.8854.2149.44
BAcc26.3826.9627.4927.8427.9827.3322.85
F117.5516.8816.9817.3017.5117.2518.36
TCGA_LUAD/molecular_subtype_dnameth1533AUC51.1149.7150.2950.7750.4950.4850.50
BAcc35.7534.7434.7036.3436.7435.6534.53
F127.8626.7426.5427.5227.8427.3026.57
TCGA_LUSC
TCGA_LUSC/CDKN2A_mutation4782AUC45.2145.6544.7643.4643.5044.5251.84
BAcc46.9248.7848.8749.1649.0148.5552.86
F146.7548.1948.1748.2648.0447.8833.30
TCGA_LUSC/RB1_mutation4782AUC54.3654.4854.7855.5255.4854.9249.13
BAcc50.4450.2450.1449.7449.8550.0849.41
F149.9849.6649.4448.8549.0049.3934.10
TCGA_LUSC/ajcc_pathologic_n4683AUC47.6247.9548.3648.8848.9548.3653.44
BAcc32.5233.2533.4533.3833.8833.3037.81
F119.9818.8518.6718.6119.0119.0232.17
TCGA_LUSC/ajcc_pathologic_stage4683AUC54.5454.1853.9753.7153.7454.0349.75
BAcc35.0734.9035.0234.7334.7934.9033.34
F125.8125.2225.1924.8224.8925.1918.79
TCGA_LUSC/ajcc_pathologic_t4784AUC51.7950.7550.7850.8750.9051.0251.59
BAcc25.7525.4125.4125.2324.9825.3623.48
F117.5215.8615.6615.1915.0815.8612.62
TCGA_LUSC/molecular_subtype_mrna1704AUC56.8158.7459.2359.6759.5258.7958.22
BAcc24.3024.7925.1225.8726.0725.2327.38
F120.7720.4420.4319.5319.3820.1114.75
TCGA_LUSC/molecular_subtype_selected1704AUC55.7655.2054.9855.0255.0955.2158.66
BAcc22.5924.2525.1524.3723.2623.9227.58
F118.1819.4220.0719.9519.5119.4214.45
TCGA_MESO
TCGA_MESO/BAP1_mutation752AUC50.9547.4247.6347.2246.5647.9646.94
BAcc48.7547.6348.0848.2647.7748.1051.52
F143.5342.0242.4042.4942.1542.5241.82
TCGA_MESO/ajcc_pathologic_n592AUC32.9232.5633.6236.1536.9134.4356.50
BAcc45.8049.9149.5349.4349.2448.7852.18
F133.9035.2934.3032.9732.7133.8338.39
TCGA_MESO/ajcc_pathologic_stage673AUC49.9853.7555.4158.2257.9955.0762.62
BAcc33.3235.6936.4337.5638.5636.3138.80
F126.4626.8427.3928.1328.9827.5627.71
TCGA_MESO/ajcc_pathologic_t734AUC50.2851.3051.5152.1252.5751.5554.85
BAcc24.3524.5824.6125.2525.7424.9125.52
F117.7916.6916.6016.6116.9816.9321.57
TCGA_OV
TCGA_OV/molecular_subtype_mrna834AUC52.5051.9551.1150.6150.6051.3649.63
BAcc25.0925.3925.1823.9423.7824.6823.77
F111.9210.6610.329.719.6310.4517.68
TCGA_OV/molecular_subtype_selected834AUC55.4953.8853.3453.9453.7854.0949.29
BAcc27.3825.6025.1525.2525.2425.7324.10
F116.4212.7712.3713.5913.6413.7617.97
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KK7-condition mean
TCGA_PAAD/CDKN2A_mutation1832AUC; BAcc; F150.89; 48.12; 45.9251.45; 48.13; 45.6051.46; 49.11; 46.5350.41; 48.97; 46.6749.76; 47.99; 45.7650.79; 48.46; 46.0958.67; 55.63; 37.54
TCGA_PAAD/SMAD4_mutation1832AUC; BAcc; F143.05; 47.68; 44.1242.82; 48.15; 43.7842.66; 48.22; 43.8241.64; 48.21; 43.7042.78; 48.45; 43.9942.59; 48.14; 43.8855.63; 54.98; 48.96
TCGA_PAAD/ajcc_pathologic_n1782AUC; BAcc; F158.68; 54.66; 50.2057.79; 54.79; 48.6657.41; 54.98; 47.9157.11; 54.30; 45.6857.09; 54.10; 45.1057.62; 54.57; 47.5160.67; 55.63; 54.32
TCGA_PAAD/ajcc_pathologic_stage1722AUC; BAcc; F146.57; 48.32; 41.5053.38; 50.14; 41.9153.83; 50.36; 41.9651.75; 50.33; 41.8651.82; 51.10; 42.5151.47; 50.05; 41.9557.86; 54.64; 49.40
TCGA_PAAD/ajcc_pathologic_t1702AUC; BAcc; F149.64; 48.60; 37.2249.73; 47.75; 35.5650.01; 47.88; 34.9148.90; 47.69; 34.1447.84; 47.58; 34.1649.22; 47.90; 35.2056.03; 52.05; 52.10
TCGA_PAAD/tumor_grade1783AUC; BAcc; F157.28; 43.46; 40.0058.71; 41.70; 37.3858.63; 40.41; 36.3157.39; 37.96; 33.8457.18; 37.19; 32.7057.84; 40.14; 36.0561.78; 44.08; 40.37
TCGA_PCPG/molecular_subtype_dnameth1703AUC; BAcc; F146.75; 28.16; 25.9249.15; 27.38; 23.5648.73; 27.77; 23.6249.22; 31.21; 27.6649.52; 30.49; 26.9848.67; 29.00; 25.5541.98; 30.79; 15.44
TCGA_PCPG/molecular_subtype_mrna1704AUC; BAcc; F155.04; 28.28; 22.1855.63; 28.93; 22.5256.12; 28.90; 22.4557.85; 30.09; 24.2159.04; 31.20; 25.1656.74; 29.48; 23.3150.42; 23.75; 14.15
TCGA_PCPG/molecular_subtype_selected1664AUC; BAcc; F157.47; 30.94; 28.0157.44; 31.13; 28.2157.41; 31.20; 28.0657.41; 31.23; 28.0657.45; 30.45; 27.5257.44; 30.99; 27.9750.86; 24.97; 13.88
TCGA_PRAD/ajcc_pathologic_n3372AUC; BAcc; F153.16; 52.27; 28.0153.10; 52.60; 27.5152.70; 52.41; 27.2053.18; 52.37; 27.5153.73; 52.50; 27.8853.17; 52.43; 27.6259.34; 52.73; 26.74
TCGA_PRAD/ajcc_pathologic_t3892AUC; BAcc; F159.42; 54.86; 52.9463.75; 57.50; 55.2065.12; 58.27; 56.0166.07; 58.69; 56.8566.63; 59.32; 57.7764.20; 57.73; 55.7571.54; 63.10; 59.20
TCGA_PRAD/molecular_subtype_cna2733AUC; BAcc; F155.01; 33.95; 23.5755.95; 34.05; 21.7856.23; 34.29; 21.4557.76; 34.59; 21.5658.60; 35.35; 22.9456.71; 34.45; 22.2649.07; 32.29; 26.31
TCGA_PRAD/molecular_subtype_other2605AUC; BAcc; F152.67; 17.51; 9.0152.59; 16.51; 7.9452.65; 16.05; 7.8053.05; 15.50; 7.9152.82; 15.20; 7.6352.76; 16.15; 8.0651.40; 20.55; 10.39
TCGA_PRAD/molecular_subtype_selected2605AUC; BAcc; F153.49; 19.29; 11.1151.67; 19.87; 11.1951.19; 19.32; 10.9952.17; 21.03; 12.0652.15; 20.96; 12.0952.14; 20.09; 11.4951.46; 20.03; 10.24
TCGA_READ/APC_mutation1572AUC; BAcc; F149.54; 49.99; 34.1647.97; 50.01; 32.2147.69; 50.27; 31.9246.60; 49.99; 32.2846.87; 50.12; 32.7347.73; 50.08; 32.6655.76; 56.36; 46.10
TCGA_READ/SMAD4_mutation1572AUC; BAcc; F144.05; 48.41; 33.8143.10; 48.59; 31.8944.09; 48.82; 31.6945.09; 49.08; 31.5845.76; 48.89; 31.3844.42; 48.76; 32.0739.99; 43.27; 39.33
TCGA_READ/ajcc_pathologic_m1412AUC; BAcc; F152.78; 50.89; 41.2554.47; 51.82; 40.4655.63; 52.50; 40.4955.42; 52.29; 39.8655.40; 52.07; 39.3854.74; 51.91; 40.2964.24; 60.08; 53.89
TCGA_READ/ajcc_pathologic_n1533AUC; BAcc; F152.64; 34.18; 24.1452.36; 33.95; 22.3452.32; 33.84; 22.0952.56; 33.82; 21.8252.51; 33.90; 21.9952.48; 33.94; 22.4861.66; 43.14; 40.97
TCGA_READ/ajcc_pathologic_stage1474AUC; BAcc; F157.04; 26.71; 22.5357.77; 24.81; 19.1857.48; 25.21; 19.7156.75; 25.56; 20.5056.86; 26.23; 21.6657.18; 25.70; 20.7259.58; 32.68; 26.42
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KK7-condition mean
TCGA_READ/ajcc_pathologic_t1483AUC53.5556.5255.6454.3654.0554.8255.29
TCGA_READ/ajcc_pathologic_t1483BAcc34.2434.8534.5734.1634.0234.3740.49
TCGA_READ/ajcc_pathologic_t1483F128.6728.3928.1728.1227.9128.2525.92
TCGA_SARC/RB1_mutation2542AUC46.7347.2447.3348.6148.9247.7731.73
TCGA_SARC/RB1_mutation2542BAcc47.4147.1346.9346.9647.1247.1143.41
TCGA_SARC/RB1_mutation2542F141.2441.4841.1941.5341.6641.4214.68
TCGA_SARC/primary_diagnosis1323AUC87.8787.7987.8288.0188.1087.9268.55
TCGA_SARC/primary_diagnosis1323BAcc68.1967.6369.2569.1768.8168.6138.45
TCGA_SARC/primary_diagnosis1323F164.2663.1064.9965.6565.1264.6227.00
TCGA_SKCM/ALK_mutation4332AUC50.8750.7050.7251.0350.7750.8250.17
TCGA_SKCM/ALK_mutation4332BAcc50.8649.2049.0649.3949.6149.6249.70
TCGA_SKCM/ALK_mutation4332F143.2741.9742.2342.8543.2942.7228.94
TCGA_SKCM/BAP1_mutation4332AUC46.8250.3152.0153.7253.9751.3761.87
TCGA_SKCM/BAP1_mutation4332BAcc48.2248.2048.3248.9448.9948.5452.24
TCGA_SKCM/BAP1_mutation4332F134.4333.3032.9933.4833.3933.527.05
TCGA_SKCM/BRAF_mutation4332AUC50.9352.1852.3253.1453.2652.3650.36
TCGA_SKCM/BRAF_mutation4332BAcc50.0050.8250.9450.9851.0750.7649.79
TCGA_SKCM/BRAF_mutation4332F141.7041.1741.1040.8140.9441.1544.38
TCGA_SKCM/CDKN2A_mutation4332AUC50.2950.1850.1950.4050.2250.2651.80
TCGA_SKCM/CDKN2A_mutation4332BAcc49.8250.5650.9350.6850.7350.5452.87
TCGA_SKCM/CDKN2A_mutation4332F144.4243.8843.7842.4341.9043.2847.31
TCGA_SKCM/EGFR_mutation4332AUC53.9552.8553.0752.0851.7052.7360.37
TCGA_SKCM/EGFR_mutation4332BAcc50.9950.6250.9850.0849.8950.5156.98
TCGA_SKCM/EGFR_mutation4332F136.7235.6935.8235.1134.8535.6450.97
TCGA_SKCM/ERBB2_mutation4332AUC57.7355.7156.4758.1159.0557.4149.32
TCGA_SKCM/ERBB2_mutation4332BAcc50.3850.9251.3751.0851.6751.0850.79
TCGA_SKCM/ERBB2_mutation4332F140.6140.3240.4240.8141.3040.6925.56
TCGA_SKCM/IDH1_mutation4332AUC49.5850.9851.4951.7951.9151.1551.33
TCGA_SKCM/IDH1_mutation4332BAcc49.0750.3550.2549.5049.2349.6850.37
TCGA_SKCM/IDH1_mutation4332F139.8940.4840.7741.0040.9840.6214.01
TCGA_SKCM/MET_mutation4332AUC55.3553.2353.0552.7552.7053.4253.09
TCGA_SKCM/MET_mutation4332BAcc50.9750.7150.9950.6350.1050.6850.17
TCGA_SKCM/MET_mutation4332F140.4439.7440.0439.9039.5239.9325.35
TCGA_SKCM/NF1_mutation4332AUC50.1550.1050.4251.6951.9050.8551.09
TCGA_SKCM/NF1_mutation4332BAcc49.8349.6849.6950.1750.3449.9449.43
TCGA_SKCM/NF1_mutation4332F145.8944.5344.1643.7643.5044.3748.67
TCGA_SKCM/PBRM1_mutation4332AUC51.9452.5752.1952.5952.3952.3451.71
TCGA_SKCM/PBRM1_mutation4332BAcc52.3252.7152.2251.2450.9651.8950.72
TCGA_SKCM/PBRM1_mutation4332F142.8942.3641.9240.7240.6141.7036.03
TCGA_SKCM/TERT_mutation4332AUC47.5247.5848.0147.9548.1747.8550.97
TCGA_SKCM/TERT_mutation4332BAcc48.6849.4850.1650.6050.5949.9048.49
TCGA_SKCM/TERT_mutation4332F137.1835.2134.8134.5734.6535.2945.90
TCGA_SKCM/ajcc_pathologic_m1962AUC49.4650.4452.3352.8852.8551.5955.99
TCGA_SKCM/ajcc_pathologic_m1962BAcc49.7849.0651.4451.1850.9550.4852.01
TCGA_SKCM/ajcc_pathologic_m1962F136.5535.1935.2634.0533.5634.9225.88
TCGA_SKCM/ajcc_pathologic_n1714AUC53.0554.1754.3753.4953.0953.6349.25
TCGA_SKCM/ajcc_pathologic_n1714BAcc24.4825.6525.8826.6026.5825.8425.69
TCGA_SKCM/ajcc_pathologic_n1714F117.9817.9817.5517.8217.9917.8616.78
TCGA_SKCM/ajcc_pathologic_stage1914AUC49.1749.7550.0249.1048.5549.3247.07
TCGA_SKCM/ajcc_pathologic_stage1914BAcc26.4425.7425.5925.3225.2425.6624.39
TCGA_SKCM/ajcc_pathologic_stage1914F117.5015.7814.7012.9813.0614.808.33
TCGA_SKCM/ajcc_pathologic_t1694AUC43.5444.4144.5745.6145.8244.7956.46
TCGA_SKCM/ajcc_pathologic_t1694BAcc20.4519.6019.3619.8719.8319.8226.70
TCGA_SKCM/ajcc_pathologic_t1694F115.2213.2412.9412.9112.8113.4324.58
TCGA_SKCM/molecular_subtype_dnameth2954AUC48.7448.7548.4948.3748.6848.6050.91
TCGA_SKCM/molecular_subtype_dnameth2954BAcc23.8423.6523.9324.1924.3423.9923.64
TCGA_SKCM/molecular_subtype_dnameth2954F119.4618.8919.0719.4819.7419.3316.67
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KKMI-Hyper 7-condition mean
TCGA_SKCM/molecular_subtype_mrna2913AUC51.8052.5452.1650.6749.6551.3665.59
TCGA_SKCM/molecular_subtype_mrna2913BAcc30.6729.5129.6029.5429.1529.6945.04
TCGA_SKCM/molecular_subtype_mrna2913F117.9516.6516.4115.6214.5416.2436.76
TCGA_SKCM/molecular_subtype_other2814AUC51.3450.9150.5350.1949.9450.5854.05
TCGA_SKCM/molecular_subtype_other2814BAcc30.0629.0528.4728.0328.1728.7629.67
TCGA_SKCM/molecular_subtype_other2814F126.3024.3623.7623.1923.4124.2123.98
TCGA_SKCM/molecular_subtype_selected2814AUC50.8850.4950.3850.4349.9750.4354.17
TCGA_SKCM/molecular_subtype_selected2814BAcc31.5430.2030.2030.4230.3030.5329.70
TCGA_SKCM/molecular_subtype_selected2814F126.4124.8324.9925.2525.1625.3324.30
TCGA_STAD/ARID1A_mutation3752AUC49.4348.2448.0248.2848.0748.4165.47
TCGA_STAD/ARID1A_mutation3752BAcc49.3249.0448.7448.2548.0648.6860.09
TCGA_STAD/ARID1A_mutation3752F138.6937.7637.5437.2937.2237.7053.92
TCGA_STAD/BAP1_mutation3752AUC57.1955.0155.4055.5155.3755.7063.74
TCGA_STAD/BAP1_mutation3752BAcc50.8848.4550.1551.8851.6250.6062.93
TCGA_STAD/BAP1_mutation3752F134.9932.5033.3433.6333.5733.6143.12
TCGA_STAD/CTNNB1_mutation3752AUC68.8470.4270.3270.1670.4370.0356.26
TCGA_STAD/CTNNB1_mutation3752BAcc63.8664.0463.7963.5863.6363.7855.58
TCGA_STAD/CTNNB1_mutation3752F151.5651.8251.9151.2651.3651.5848.09
TCGA_STAD/ERBB2_mutation3752AUC45.6143.2142.1941.0841.6742.7560.21
TCGA_STAD/ERBB2_mutation3752BAcc50.2050.3050.6849.7649.3450.0656.56
TCGA_STAD/ERBB2_mutation3752F147.9549.1849.6849.3249.0849.0444.02
TCGA_STAD/FBXW7_mutation3752AUC52.7349.2349.2148.9949.3749.9075.02
TCGA_STAD/FBXW7_mutation3752BAcc52.2449.0848.6548.1148.2249.2669.91
TCGA_STAD/FBXW7_mutation3752F147.9746.6246.4646.3546.5446.7954.78
TCGA_STAD/PBRM1_mutation3752AUC44.5043.3643.6944.2444.1143.9881.85
TCGA_STAD/PBRM1_mutation3752BAcc48.3149.2349.3250.2650.4549.5164.96
TCGA_STAD/PBRM1_mutation3752F146.6147.2347.3647.9748.2347.4831.39
TCGA_STAD/PIK3CA_mutation3752AUC51.0250.1349.1947.9447.5349.1674.62
TCGA_STAD/PIK3CA_mutation3752BAcc50.3451.2351.1651.2350.9150.9867.53
TCGA_STAD/PIK3CA_mutation3752F146.5647.6047.5647.8247.7647.4653.60
TCGA_STAD/SETD2_mutation3752AUC50.2049.7949.6749.6449.4549.7561.22
TCGA_STAD/SETD2_mutation3752BAcc48.2148.7349.6150.3350.0749.3959.35
TCGA_STAD/SETD2_mutation3752F138.4838.9539.1340.3440.8039.5446.43
TCGA_STAD/SMAD4_mutation3752AUC47.2649.8051.0853.9854.7751.3863.92
TCGA_STAD/SMAD4_mutation3752BAcc47.7150.4851.2453.0853.5751.2158.24
TCGA_STAD/SMAD4_mutation3752F143.8145.9246.4447.7948.2046.4346.38
TCGA_STAD/TERT_mutation3752AUC45.8344.4944.4944.4144.4544.7359.87
TCGA_STAD/TERT_mutation3752BAcc46.8049.8050.4849.5948.8749.1156.47
TCGA_STAD/TERT_mutation3752F142.9944.5044.8444.7544.1944.2535.08
TCGA_STAD/ajcc_pathologic_m3572AUC49.1750.6251.0152.5252.5051.1653.31
TCGA_STAD/ajcc_pathologic_m3572BAcc49.0950.0349.0651.6852.1550.4047.06
TCGA_STAD/ajcc_pathologic_m3572F136.6335.6935.3935.6435.4835.7725.83
TCGA_STAD/ajcc_pathologic_n3704AUC49.3049.1549.3149.1849.1549.2255.25
TCGA_STAD/ajcc_pathologic_n3704BAcc25.0724.5624.9125.0225.0124.9128.30
TCGA_STAD/ajcc_pathologic_n3704F121.5520.2420.2920.0519.9920.4218.05
TCGA_STAD/ajcc_pathologic_stage3674AUC58.8059.4359.6159.2259.0559.2256.58
TCGA_STAD/ajcc_pathologic_stage3674BAcc30.6630.7230.9730.3430.5630.6530.26
TCGA_STAD/ajcc_pathologic_stage3674F125.6325.4525.6725.4125.6625.5618.48
TCGA_STAD/ajcc_pathologic_t3754AUC56.4558.4958.9759.5159.8358.6560.60
TCGA_STAD/ajcc_pathologic_t3754BAcc28.7032.1232.5433.8934.4432.3436.15
TCGA_STAD/ajcc_pathologic_t3754F122.1423.4223.7424.5024.8723.7328.08
TCGA_STAD/molecular_subtype_other3224AUC57.5958.0558.0758.5959.0258.2654.02
TCGA_STAD/molecular_subtype_other3224BAcc29.4430.7430.7331.3131.0330.6529.92
TCGA_STAD/molecular_subtype_other3224F124.3526.2826.5927.7327.6826.5324.96
TCGA_STAD/molecular_subtype_selected3224AUC57.1458.0858.4659.0059.2658.3953.92
TCGA_STAD/molecular_subtype_selected3224BAcc31.4132.8432.9332.4832.5632.4429.63
TCGA_STAD/molecular_subtype_selected3224F126.3228.5929.1329.6930.2528.8024.56
TCGA_STAD/tumor_grade3663AUC65.8070.7272.0874.1474.5971.4760.61
TCGA_STAD/tumor_grade3663BAcc41.5342.5843.0544.3444.9143.2842.05
TCGA_STAD/tumor_grade3663F141.2342.3142.8044.1144.6843.0334.21
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KK7-condition mean
TCGA_TGCT
TCGA_TGCT/ajcc_pathologic_n1052AUC53.9350.3450.6850.6651.0751.3343.46
BAcc50.9549.0149.0749.3549.4449.5750.33
F140.9638.2637.8738.1738.4638.7419.35
TCGA_TGCT/ajcc_pathologic_stage2413AUC51.7453.1752.9151.9651.4652.2556.28
BAcc37.1636.5536.4335.7635.5936.3035.23
F123.1021.9421.9721.8121.8322.1316.04
TCGA_TGCT/ajcc_pathologic_t2332AUC55.4056.4957.1056.6355.7356.2763.46
BAcc51.5451.6351.8851.9951.5451.7158.72
F140.5339.3839.3939.8839.5139.7452.26
TCGA_TGCT/primary_diagnosis1703AUC83.9984.0484.0583.9384.1284.0376.01
BAcc60.9967.0067.0866.7367.2665.8155.08
F150.6355.3755.1554.4554.9154.1044.95
TCGA_THCA
TCGA_THCA/BRAF_mutation5062AUC39.6438.9138.2238.1337.8338.5557.63
BAcc47.3948.7448.4048.1348.0348.1454.93
F142.8142.7541.8441.2741.2041.9749.48
TCGA_THCA/ajcc_pathologic_n4562AUC54.9857.6959.0260.0060.4758.4360.65
BAcc51.6951.9652.1652.0851.8351.9454.70
F141.2440.6040.6440.3539.9740.5650.04
TCGA_THCA/ajcc_pathologic_stage5044AUC53.4053.7253.9453.7053.6253.6856.49
BAcc25.2525.1325.2925.4225.6325.3426.50
F115.1713.5913.4113.4813.6513.8624.51
TCGA_THCA/ajcc_pathologic_t5044AUC54.5555.6255.8755.6355.5255.4455.95
BAcc25.9226.3325.9725.1624.8825.6530.02
F122.7922.2421.5820.2719.8421.3423.41
TCGA_THCA/molecular_subtype_cna4934AUC44.4743.4943.5443.2143.2343.5955.43
BAcc17.2214.2213.7412.2812.6514.0228.17
F116.4714.4214.0513.0112.8914.1719.17
TCGA_THCA/molecular_subtype_dnameth4954AUC49.4048.6148.5749.0649.3048.9950.15
BAcc24.5122.9522.6021.9622.3622.8819.01
F119.4117.7117.1916.3816.2917.4017.92
TCGA_THCA/molecular_subtype_other4573AUC78.0979.2979.6380.4880.5779.6142.44
BAcc56.1156.1557.8860.5261.6658.4627.03
F155.6455.4756.7158.0358.9656.9628.05
TCGA_THYM
TCGA_THYM/primary_diagnosis522AUC69.9076.5280.1981.7881.4377.9664.23
BAcc50.6150.7551.4051.2852.0951.2260.44
F135.5332.3933.6433.4435.0434.0158.47
TCGA_UCEC
TCGA_UCEC/ALK_mutation5052AUC46.9145.2145.1545.4845.6845.6958.24
BAcc48.0046.7246.1245.9646.1646.5955.69
F146.2445.4545.1344.9145.0045.3542.83
TCGA_UCEC/APC_mutation5052AUC49.8649.8749.0447.8748.0748.9464.74
BAcc49.3548.9448.9048.5548.5948.8760.25
F136.9434.9434.5434.0133.9734.8852.45
TCGA_UCEC/ARID1A_mutation5052AUC48.9748.1048.3747.9347.7248.2261.48
BAcc49.8550.8850.9050.5150.5250.5356.83
F140.4040.3840.2139.8040.0040.1656.03
TCGA_UCEC/ATRX_mutation5052AUC51.3150.9551.2250.6950.4250.9263.05
BAcc49.6849.2449.2849.3349.2849.3659.23
F132.7831.2731.1931.1531.0931.4953.42
TCGA_UCEC/BAP1_mutation5052AUC55.2053.1353.6053.9153.6253.8965.25
BAcc50.4349.4349.2049.6749.6249.6760.66
F141.7540.2939.9940.1440.1440.4643.20
TCGA_UCEC/BRAF_mutation5052AUC48.4549.4150.4350.7751.0650.0267.10
BAcc49.4747.6048.2148.3648.4248.4161.00
F142.5340.8440.8640.3940.2040.9648.73
TCGA_UCEC/CTNNB1_mutation5052AUC48.7547.8747.8247.3347.3647.8348.71
BAcc49.1748.1247.7547.3147.5447.9851.30
F143.1641.2840.7940.2840.5841.2250.92
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KK7-condition mean
TCGA_UCEC/EGFR_mutation5052AUC<br>BAcc<br>F149.35<br>49.78<br>46.5748.14<br>48.80<br>46.7147.51<br>49.17<br>47.1046.80<br>48.31<br>46.6046.57<br>48.03<br>46.5247.67<br>48.82<br>46.7070.60<br>64.51<br>57.09
TCGA_UCEC/ERBB2_mutation5052AUC<br>BAcc<br>F144.98<br>45.68<br>44.5045.00<br>46.76<br>46.0145.68<br>47.21<br>46.2446.75<br>46.42<br>45.6946.75<br>46.35<br>45.6845.83<br>46.48<br>45.6265.63<br>64.91<br>52.71
TCGA_UCEC/FBXW7_mutation5052AUC<br>BAcc<br>F146.37<br>47.81<br>42.1346.80<br>49.05<br>42.2346.90<br>48.67<br>41.7947.84<br>49.81<br>42.2548.22<br>49.99<br>42.1147.23<br>49.07<br>42.1054.31<br>54.19<br>51.29
TCGA_UCEC/IDH2_mutation5052AUC<br>BAcc<br>F151.60<br>52.11<br>33.0351.34<br>51.19<br>30.3151.07<br>51.07<br>29.9451.18<br>50.57<br>29.1250.54<br>50.61<br>29.2751.15<br>51.11<br>30.3374.24<br>65.36<br>49.65
TCGA_UCEC/KRAS_mutation5052AUC<br>BAcc<br>F150.75<br>49.73<br>40.3749.76<br>49.33<br>38.3149.90<br>49.76<br>38.1850.02<br>50.09<br>38.0350.39<br>50.21<br>38.2550.17<br>49.83<br>38.6353.47<br>52.94<br>48.74
TCGA_UCEC/MET_mutation5052AUC<br>BAcc<br>F151.75<br>52.57<br>40.1249.10<br>50.89<br>37.8548.97<br>50.68<br>37.5948.96<br>50.29<br>37.1248.92<br>50.34<br>37.1749.54<br>50.95<br>37.9772.28<br>66.37<br>53.37
TCGA_UCEC/NF1_mutation5052AUC<br>BAcc<br>F147.02<br>49.74<br>47.2847.11<br>50.28<br>47.2147.22<br>50.42<br>47.1546.52<br>49.91<br>46.1846.49<br>49.56<br>45.5846.87<br>49.98<br>46.6869.39<br>63.18<br>60.99
TCGA_UCEC/PBRM1_mutation5052AUC<br>BAcc<br>F148.99<br>51.03<br>44.9249.25<br>51.10<br>45.4749.11<br>51.23<br>45.5248.60<br>50.99<br>44.7048.24<br>51.16<br>44.5948.84<br>51.10<br>45.0474.63<br>66.21<br>58.02
TCGA_UCEC/PIK3CA_mutation5052AUC<br>BAcc<br>F147.37<br>48.67<br>47.3348.78<br>49.96<br>48.1449.34<br>50.19<br>48.3049.46<br>50.32<br>48.3749.54<br>50.33<br>48.3448.90<br>49.90<br>48.1055.92<br>53.36<br>51.02
TCGA_UCEC/PTEN_mutation5052AUC<br>BAcc<br>F151.66<br>48.16<br>40.1750.14<br>46.83<br>37.2449.59<br>46.45<br>36.5748.77<br>45.95<br>36.0448.07<br>45.68<br>35.8749.65<br>46.61<br>37.1849.24<br>54.20<br>47.69
TCGA_UCEC/RB1_mutation5052AUC<br>BAcc<br>F150.43<br>51.58<br>50.4848.49<br>51.27<br>50.2448.21<br>50.55<br>49.4547.88<br>50.55<br>49.4547.64<br>50.58<br>49.4848.53<br>50.91<br>49.8261.17<br>57.56<br>53.02
TCGA_UCEC/SETD2_mutation5052AUC<br>BAcc<br>F145.48<br>47.49<br>37.6247.24<br>48.77<br>37.4347.07<br>48.83<br>37.0046.53<br>47.63<br>35.9846.02<br>46.88<br>35.6346.47<br>47.92<br>36.7371.46<br>64.52<br>60.68
TCGA_UCEC/SMAD4_mutation5052AUC<br>BAcc<br>F147.13<br>47.55<br>36.6847.96<br>48.28<br>36.3047.51<br>48.40<br>36.0046.93<br>47.63<br>34.9845.29<br>46.49<br>34.4246.97<br>47.67<br>35.6876.15<br>68.47<br>46.42
TCGA_UCEC/TERT_mutation5052AUC<br>BAcc<br>F146.27<br>48.30<br>44.4647.41<br>47.83<br>44.6147.68<br>47.74<br>44.4248.51<br>49.54<br>44.5748.73<br>49.79<br>44.2647.72<br>48.64<br>44.4769.20<br>63.51<br>55.33
TCGA_UCEC/TP53_mutation5052AUC<br>BAcc<br>F149.03<br>50.54<br>47.8149.52<br>51.84<br>48.5349.90<br>51.67<br>48.2750.99<br>52.04<br>48.4551.38<br>52.15<br>48.6350.16<br>51.65<br>48.3439.68<br>43.21<br>40.06
TCGA_UCEC/molecular_subtype_other3553AUC<br>BAcc<br>F152.30<br>33.60<br>32.6154.07<br>34.80<br>33.4354.12<br>34.87<br>33.5253.83<br>33.89<br>32.3953.37<br>33.64<br>32.1253.54<br>34.16<br>32.8152.27<br>30.76<br>26.68
TCGA_UCEC/molecular_subtype_selected4684AUC<br>BAcc<br>F158.24<br>31.13<br>25.5759.04<br>30.93<br>24.4959.40<br>30.98<br>24.3959.16<br>31.58<br>24.6158.92<br>31.73<br>24.6558.96<br>31.27<br>24.7458.80<br>31.06<br>27.02
TCGA_UCEC/primary_diagnosis4542AUC<br>BAcc<br>F186.58<br>77.28<br>74.2988.36<br>79.17<br>76.0488.60<br>79.72<br>76.4188.79<br>80.41<br>76.5588.64<br>80.40<br>76.2688.19<br>79.40<br>75.9156.52<br>52.93<br>39.97
TCGA_UCEC/tumor_grade4953AUC<br>BAcc<br>F173.12<br>41.27<br>30.2977.10<br>41.26<br>28.5178.01<br>41.62<br>28.9079.47<br>41.78<br>29.1979.95<br>41.94<br>29.4277.53<br>41.57<br>29.2674.42<br>47.94<br>35.27
TCGA_UVM
TCGA_UVM/BAP1_mutation802AUC<br>BAcc<br>F145.23<br>47.56<br>34.2740.12<br>48.98<br>33.5540.99<br>48.36<br>32.2342.37<br>48.16<br>31.8342.60<br>48.41<br>32.0942.26<br>48.29<br>32.8057.62<br>50.45<br>17.64
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KK7-condition mean
TCGA_UVM/ajcc_pathologic_stage752AUC51.6756.9557.7358.9959.6857.0152.98
TCGA_UVM/ajcc_pathologic_stage752BAcc50.0151.2751.5951.8951.9451.3452.56
TCGA_UVM/ajcc_pathologic_stage752F140.3240.0440.2740.1039.9240.1342.91
TCGA_UVM/ajcc_pathologic_t803AUC50.9252.7052.7052.6052.3652.2547.38
TCGA_UVM/ajcc_pathologic_t803BAcc33.5933.3033.8432.8132.4933.2132.75
TCGA_UVM/ajcc_pathologic_t803F123.9223.5723.8023.1822.9423.4828.52
bc_therapy
bc_therapy/er_status1662AUC48.6948.9248.4546.0346.2747.6744.94
bc_therapy/er_status1662BAcc47.3849.1148.1347.3948.2648.0645.74
bc_therapy/er_status1662F145.0845.4144.0942.5142.7943.9844.49
bc_therapy/grade1662AUC62.4065.4066.2867.7867.0765.7872.45
bc_therapy/grade1662BAcc58.6960.8961.1062.9861.8161.0951.42
bc_therapy/grade1662F158.6660.7260.9863.1661.8561.0741.19
bc_therapy/her2_status1662AUC62.0063.8064.4260.8459.5362.1263.13
bc_therapy/her2_status1662BAcc56.3857.1657.2455.7855.0856.3360.03
bc_therapy/her2_status1662F147.5247.2147.2145.8745.5446.6758.84
bracs
bracs/coarse5473AUC72.2073.5673.5772.1971.0172.5168.57
bracs/coarse5473BAcc50.3350.2550.0648.4747.2549.2736.24
bracs/coarse5473F149.0648.2148.0846.3745.0047.3428.48
bracs/fine5477AUC71.9273.8174.3073.9672.4273.2860.32
bracs/fine5477BAcc34.3236.1835.5134.4133.3934.7617.17
bracs/fine5477F126.5327.5927.4528.0428.6027.648.45
camelyon17
camelyon17/breast_cancer_metastases4994AUC41.7945.4246.6350.1451.8647.1768.57
camelyon17/breast_cancer_metastases4994BAcc24.1128.8830.4132.7030.9229.4030.81
camelyon17/breast_cancer_metastases4994F116.8818.7219.3319.0616.0218.0027.27
cptac_all
cptac_all/organ199310AUC94.3994.8995.0195.1895.2394.9481.94
cptac_all/organ199310BAcc75.7177.4577.7877.0076.6176.9134.32
cptac_all/organ199310F176.0377.3777.6076.6676.1676.7625.85
cptac_brca
cptac_brca/Immune_class1033AUC53.8752.7852.7352.2552.0852.7451.72
cptac_brca/Immune_class1033BAcc37.0836.2336.3135.3334.8935.9733.94
cptac_brca/Immune_class1033F126.9424.7924.7123.8623.7324.8128.70
cptac_brca/PIK3CA_mutation1032AUC45.2948.8849.1349.1149.0848.3042.54
cptac_brca/PIK3CA_mutation1032BAcc46.3449.6850.0349.6550.1249.1649.41
cptac_brca/PIK3CA_mutation1032F142.8445.3745.5944.8045.1544.7545.09
cptac_ccrcc
cptac_ccrcc/Immune_class1033AUC54.3055.2654.5254.1354.0754.4658.15
cptac_ccrcc/Immune_class1033BAcc34.9134.5034.2534.1634.0234.3739.49
cptac_ccrcc/Immune_class1033F123.8021.8721.3620.9020.6521.7232.99
cptac_ccrcc/PBRM1_mutation1032AUC47.7844.5544.3042.7942.0244.2953.21
cptac_ccrcc/PBRM1_mutation1032BAcc48.6248.4948.5149.5349.4648.9251.01
cptac_ccrcc/PBRM1_mutation1032F141.5740.0339.9540.4940.2040.4549.17
cptac_ccrcc/VHL_mutation1032AUC45.6347.2647.9347.9548.2147.4050.68
cptac_ccrcc/VHL_mutation1032BAcc47.9349.7850.3150.8151.0249.9751.11
cptac_ccrcc/VHL_mutation1032F132.2729.5929.1028.9128.9629.7724.31
cptac_coad
cptac_coad/APC_mutation942AUC59.7761.2360.7762.0161.6961.0961.83
cptac_coad/APC_mutation942BAcc56.0854.2054.1453.9854.3854.5658.64
cptac_coad/APC_mutation942F151.9549.2948.6147.8048.1849.1751.12
cptac_coad/ARID1A_mutation942AUC51.0554.5152.8553.2153.7953.0856.84
cptac_coad/ARID1A_mutation942BAcc49.3050.5450.1251.5452.0850.7254.74
cptac_coad/ARID1A_mutation942F136.3536.2236.2938.3739.2637.3045.96
cptac_coad/Immune_class943AUC48.9150.8751.4251.8051.3850.8854.51
cptac_coad/Immune_class943BAcc32.8334.1533.9533.1532.8233.3835.89
cptac_coad/Immune_class943F121.9121.8121.4320.6720.5321.2729.86
cptac_coad/KRAS_mutation942AUC50.2050.6050.7751.8851.9851.0947.82
cptac_coad/KRAS_mutation942BAcc49.2451.5251.2252.4852.6251.4249.89
cptac_coad/KRAS_mutation942F139.7238.5237.2938.1338.5138.4344.30
TaskNNCCMetricMI-Zero K=1K=1MI-Zero K=5K=5MI-Zero K=10K=10MI-Zero K=50K=50MI-Zero K=100K=100MI-Zero Mean KKMI-Hyper 7-condition mean
cptac_coad/MSI_H932AUC42.9941.0542.1441.2942.3841.9748.74
BAcc47.8246.0846.4945.7446.1646.4650.78
F139.8036.6136.3037.8439.1437.9344.18
cptac_coad/PIK3CA_mutation942AUC48.3847.0145.3843.3742.8945.4048.10
BAcc48.3948.6848.7548.2048.4548.4950.34
F144.2743.8543.4543.0543.5943.6449.52
cptac_coad/SETD1B_mutation942AUC49.1647.8947.6648.0548.1548.1857.43
BAcc48.8549.7248.2346.9646.8448.1255.42
F137.4037.9536.1637.0137.4137.1949.76
cptac_coad/TP53_mutation942AUC51.8149.8850.1250.4550.7750.6133.61
BAcc50.1549.9150.2949.8749.7850.0038.09
F137.9436.3436.6436.5437.0136.9034.94
cptac_gbm
cptac_gbm/EGFR_mutation992AUC48.9146.3745.2445.4446.1546.4232.62
BAcc50.0648.2247.2447.5247.6748.1442.67
F141.3438.6737.7638.3338.8138.9827.17
cptac_gbm/Immune_class993AUC51.7451.8451.6150.7850.7251.3455.83
BAcc34.1233.2733.7433.5633.6633.6733.19
F121.7420.0120.3719.9820.1420.4518.37
cptac_gbm/TP53_mutation992AUC54.5857.1257.7956.6855.6956.3730.25
BAcc51.3451.8152.1351.9851.2651.7140.49
F142.5441.9142.2142.2241.6142.1036.62
cptac_hnsc
cptac_hnsc/CASP8_mutation1072AUC64.5270.4471.7173.3374.9170.9861.77
BAcc59.5459.8259.9059.6959.6659.7255.20
F150.6350.1550.4549.2248.9149.8739.76
cptac_hnsc/Histologic_Grade1073AUC53.5353.6154.4458.7759.9256.0568.61
BAcc35.8134.8737.1237.7738.6736.8547.04
F129.6129.9532.5035.5136.2632.7739.38
cptac_hnsc/Immune_class1073AUC46.9046.5446.8846.6146.9346.7742.33
BAcc30.8631.7531.6830.3629.9530.9227.23
F120.6319.5919.3618.1317.6919.0821.10
cptac_lscc
cptac_lscc/ARID1A_mutation1082AUC62.2660.9760.9361.3861.3461.3841.91
BAcc57.0356.3057.0756.8856.0956.6747.80
F132.4330.4930.9531.4931.3731.3540.01
cptac_lscc/Immune_class1083AUC48.1549.3049.2849.8450.1849.3546.46
BAcc30.9131.8531.6131.7031.7431.5630.16
F119.1518.7318.3518.3018.3918.5825.24
cptac_lscc/KEAP1_mutation1082AUC46.8644.9544.5741.5340.3143.6463.98
BAcc47.2348.8148.2847.1446.6947.6356.18
F145.5746.0045.8245.0844.8745.4753.96
cptac_luad
cptac_luad/EGFR_mutation1082AUC62.9864.2064.5564.2264.1464.0247.75
BAcc56.3155.9055.5255.8156.2755.9647.46
F150.8150.0049.3950.2551.0250.2938.24
cptac_luad/Immune_class1083AUC52.4153.3252.7652.5352.5752.7249.60
BAcc32.7633.0633.3333.3133.4433.1830.42
F118.6318.3818.6718.4618.4818.5222.76
cptac_luad/STK11_mutation1082AUC41.1039.3438.6639.6740.0939.7756.46
BAcc46.1445.6344.2145.1245.1045.2453.81
F134.5532.8631.9733.0633.9133.2748.30
cptac_luad/TP53_mutation1082AUC49.5547.9147.2946.0145.6547.2840.76
BAcc49.0548.1448.2547.1147.0247.9244.69
F142.4240.8140.9039.5739.4640.6340.90
cptac_lung
cptac_lung/subtype2062AUC99.0399.2399.2999.3299.3699.2594.93
BAcc94.3895.1895.4195.6996.2195.3886.76
F194.3895.1795.4195.6996.2195.3786.75
TaskNNCCMetricK=1K=1K=5K=5K=10K=10K=50K=50K=100K=100Mean KKMI-Hyper 7-condition mean
cptac_pda
cptac_pda/Immune_class1053AUC54.5053.7053.1151.6351.3552.8655.01
cptac_pda/Immune_class1053BAcc33.6433.6833.7533.9433.9633.7936.73
cptac_pda/Immune_class1053F122.0320.4120.4420.4020.3520.7330.30
cptac_pda/SMAD4_mutation1052AUC51.2155.1558.0160.2859.3756.8056.76
cptac_pda/SMAD4_mutation1052BAcc49.0149.7449.4749.6649.9049.5657.31
cptac_pda/SMAD4_mutation1052F145.2145.4445.0445.2545.5345.3053.88
cptac_ucec
cptac_ucec/CTNNB1_mutation932AUC53.1550.4551.2451.9352.6751.8944.11
cptac_ucec/CTNNB1_mutation932BAcc52.7552.4453.3653.7154.4953.3546.01
cptac_ucec/CTNNB1_mutation932F148.9447.6347.7747.3847.6547.8742.68
cptac_ucec/Immune_class943AUC55.9955.1255.3655.7156.0655.6557.60
cptac_ucec/Immune_class943BAcc37.4135.7635.6334.6934.6135.6239.50
cptac_ucec/Immune_class943F130.6128.0127.6525.8925.6327.5636.38
cptac_ucec/PTEN_mutation932AUC46.5445.8845.9245.3645.2845.7926.39
cptac_ucec/PTEN_mutation932BAcc44.1944.5245.2445.3545.9545.0527.86
cptac_ucec/PTEN_mutation932F143.6744.3745.0345.1845.7944.8124.37
dhmc_kidney
dhmc_kidney/morphological_subtyping5635AUC84.1784.0283.5180.6978.6282.2071.88
dhmc_kidney/morphological_subtyping5635BAcc67.5266.0965.6658.1453.4762.1840.81
dhmc_kidney/morphological_subtyping5635F158.6257.7457.3151.1546.5854.2826.00
dhmc_luad
dhmc_luad/histologic_pattern1435AUC75.4976.4876.9578.5079.0477.2965.97
dhmc_luad/histologic_pattern1435BAcc38.6038.2438.2139.2739.8938.8425.73
dhmc_luad/histologic_pattern1435F129.6527.1727.1128.4929.5628.398.75
ebrains
ebrains/diagnosis231930AUC43.3243.0642.9542.8242.8042.9944.13
ebrains/diagnosis231930BAcc1.180.950.911.011.101.032.54
ebrains/diagnosis231930F10.820.650.600.650.720.691.63
ebrains/diagnosis_group231912AUC48.1448.1948.4349.1449.5248.6847.89
ebrains/diagnosis_group231912BAcc9.479.389.479.629.629.517.58
ebrains/diagnosis_group231912F111.0111.1211.1010.9910.9911.045.53
imp
imp/grade53333AUC86.4988.5889.0989.5789.3388.6180.89
imp/grade53333BAcc56.5356.3255.9354.3852.7255.1853.58
imp/grade53333F138.2838.1937.8936.6335.1937.2450.11
imp_cervix
imp_cervix/dysplasia_grading6004AUC73.8276.8476.8675.0573.8575.2846.47
imp_cervix/dysplasia_grading6004BAcc46.3049.1247.5537.0430.4142.0824.96
imp_cervix/dysplasia_grading6004F140.4742.3040.4228.2619.3434.1615.22
mut-het-rcc
mut-het-rcc/BAP1_mutation12912AUC39.7238.3437.8137.3737.3138.1170.48
mut-het-rcc/BAP1_mutation12912BAcc45.3945.0245.2144.8844.8145.0659.97
mut-het-rcc/BAP1_mutation12912F128.6227.4527.2326.5326.3127.2338.25
mut-het-rcc/PBRM1_mutation12912AUC47.0445.5644.9543.8343.2344.9253.08
mut-het-rcc/PBRM1_mutation12912BAcc49.2949.0448.8948.7548.6148.9252.22
mut-het-rcc/PBRM1_mutation12912F139.3238.0437.5836.6436.0737.5349.74
mut-het-rcc/SETD2_mutation12912AUC43.1941.3040.3939.2738.8940.6169.15
mut-het-rcc/SETD2_mutation12912BAcc47.5147.4847.4847.3847.3347.4455.11
mut-het-rcc/SETD2_mutation12912F139.3337.5137.0336.2536.0637.2453.05
natbrca
natbrca/lymphovascular_invasion532AUC43.5456.6255.8455.5253.4252.9953.79
natbrca/lymphovascular_invasion532BAcc43.9149.5648.8045.9646.2646.9049.76
natbrca/lymphovascular_invasion532F142.9248.3347.2544.1444.2245.3739.40

Table S1. All 308 tasks under the same 112-group partition. Each cell lists AUC, BAcc and macro-F1 (%) from top to bottom. Each MI-Zero KK column averages metrics over 50 prompts; Mean-KK averages all 250 conditions. MI-Hyper uses the fixed five-fold checkpoints and averages metrics over seven predefined paired text conditions. All columns use metric averaging, without selecting the best condition for each task. NN is the number of task–bag records and CC the number of classes. Blue task IDs mark the six main-text examples; MI-Zero scores are gray.

Overall Performance of MI-Hyper

Across all 308 tasks, MI-Hyper achieves mean AUC and BAcc of 58.24 and 45.66, compared with 56.38 and 44.49 for MI-Zero (Mean-K), corresponding to gains of 1.85 and 1.17 percentage points. Keeping the MI-Hyper configuration fixed, we stratify these results by endpoint type, anatomy, bag structure and dataset source.

Table 1 and Table 2 compare MI-Zero and MI-Hyper AUC, BAcc and paired differences across all 16 endpoint types and 25 anatomical display groups, retaining every group and its task count. Supplementary Table S1 provides all three task-level metrics.

Endpoint typeTask NumAUC↑ MI-ZeroAUC↑ MI-HyperAUC↑ Δ (pp)BAcc↑ MI-ZeroBAcc↑ MI-HyperBAcc↑ Δ (pp)
Mutation12249.2454.35+5.1149.5753.11+3.54
Stage6954.8956.85+1.9638.4540.71+2.26
Molecular subtype3855.4854.92−0.5630.5332.31+1.78
Grade2967.6568.02+0.3744.3544.94+0.59
Histological subtype1981.8472.33−9.5158.9446.37−12.58
Immune class951.8652.36+0.4933.6134.06+0.46
Invasion479.6976.18−3.5155.7257.65+1.93
Benign/malignant473.5984.49+10.9150.8568.55+17.71
Procedure363.6956.53−7.1643.2731.13−12.14
Tumor detection347.4251.08+3.6649.8843.48−6.40
Organ class296.5372.47−24.0674.6830.66−44.02
Receptor status254.9054.03−0.8652.1952.88+0.69
Histological pattern177.2965.97−11.3238.8425.73−13.11
Metaplasia163.5676.37+12.8157.8351.58−6.25
Metastasis147.1768.57+21.4129.4030.81+1.41
Molecular status141.9748.74+6.7746.4650.78+4.32
All tasks30856.3858.24+1.8544.4945.66+1.17

Table 1. Results by endpoint type. AUC and BAcc (%) for all 16 endpoint types. Task Num denotes the number of tasks; tasks within each group are equally weighted. Δ is MI-Hyper minus MI-Zero in percentage points, computed before rounding. Gains are green and decreases gray; higher scores in non-summary rows are bold. All three metrics are reported in the supplement.

AnatomyTask NumAUC↑ MI-ZeroAUC↑ MI-HyperAUC↑ Δ (pp)BAcc↑ MI-ZeroBAcc↑ MI-HyperBAcc↑ Δ (pp)
Colorectal3755.4059.62+4.2246.9850.28+3.30
Lung3455.6255.87+0.2544.8345.50+0.66
Uterus2951.8260.55+8.7448.3654.60+6.24
Breast2759.2855.66−3.6243.8139.93−3.88
Kidney2454.9157.73+2.8244.0346.15+2.12
Stomach2259.0965.77+6.6847.5750.57+3.00
Skin1951.1053.45+2.3541.4743.07+1.60
Bladder1759.1161.81+2.6949.4247.54−1.88
Brain1452.6644.76−7.9037.6035.63−1.97
Prostate1058.3964.21+5.8242.2736.12+6.15
Cervix966.8263.53−3.2947.2647.43+0.16
Lip (reg.)951.1055.15+4.0531.9834.50+2.53
Liver/biliary850.8053.25+2.4541.7542.10+0.35
Pancreas852.4057.80+5.4046.5851.38+4.81
Adrenal gland754.3652.39−1.9736.0937.15+1.06
Esophagus768.9174.70+5.7953.1661.50+8.34
Thyroid754.0454.11+0.0735.2034.34−0.87
Multiple sites485.7969.50−16.2958.4230.71−27.71
Testis460.9759.80−1.1750.8549.84−1.01
Eye/adnexa350.5152.66+2.1544.2845.25+0.97
Head/neck357.9457.57−0.3742.5043.16+0.66
Retro./perit.252.7249.46−3.2625.2023.93−1.27
Soft tissue267.8450.14−17.7057.8640.93−16.93
Lymph node147.1768.57+21.4129.4030.81+1.41
Thymus177.9664.23−13.7351.2260.44+9.22
All tasks30856.3858.24+1.8544.4945.66+1.17

Table 2. Results by anatomical group. AUC and BAcc (%) for all 25 display groups. Task Num denotes the number of tasks; tasks within each group are equally weighted. Formatting follows Table 1. Lip (reg.) retains the registry label; Retro./perit. denotes retroperitoneum/peritoneum. Full group names and all three metrics are given in the supplement.

By endpoint type (Table 1), the 122 mutation tasks gain 5.11 AUC and 3.54 BAcc points, while the 69 staging tasks gain 1.96 and 2.26 points. The four benign/malignant tasks gain 10.91 and 17.71 points. For histological subtyping, MI-Hyper achieves 72.33 AUC, compared with 81.84 for MI-Zero. The overall mean therefore combines different endpoint-level results, as the mutation, staging and histological-subtyping comparisons illustrate.

By anatomy (Table 2), the 37 colorectal tasks gain 4.22 AUC and 3.30 BAcc points, and the 29 uterine tasks gain 8.74 and 6.24 points. Anatomical groups differ in endpoint composition, so their means reflect both anatomical coverage and task composition. Supplementary Figure S1 shows uneven task coverage across organs. These registry groupings do not evaluate transfer to held-out organs.

Table 3 connects performance to sequence length and class count. On the 53 tasks whose average bag length exceeds 5,000 patches, MI-Hyper gains 7.54 AUC and 5.51 BAcc points. Inference uses all stored patches, whereas training follows the sampling strategy in Methods. Because endpoints, sources and class counts also vary across length groups, these comparisons show performance on long bags without isolating a causal effect of sequence length.

AxisGroupTask NumAUC↑ MI-ZeroAUC↑ MI-HyperAUC↑ Δ (pp)BAcc↑ MI-ZeroBAcc↑ MI-HyperBAcc↑ Δ (pp)
Bag length≤ 1,0003367.0466.90-0.1549.0045.55-3.44
Bag length1,000–2,5002759.4657.69-1.7747.9347.29-0.63
Bag length2,500–5,00019555.4756.62+1.1542.4943.51+1.02
Bag length> 5,0005351.5259.06+7.5447.2752.78+5.51
Class countBinary17453.5157.37+3.8651.8354.57+2.73
Class countMulticlass13460.1159.36-0.7534.9534.08-0.86

Table 3. Results by bag length and class count. Task Num denotes the number of tasks. Length groups use the task-average patch count Nˉ\bar{N}: Nˉ≤1,000\bar{N} \le1{,}000, 1,000<Nˉ≤2,5001{,}000 < \bar{N} \le2{,}500, 2,500<Nˉ≤5,0002{,}500 < \bar{N} \le5{,}000 and Nˉ>5,000\bar{N} > 5{,}000. Class-count groups distinguish binary and multiclass tasks. Each partition covers all 308 tasks. AUC and BAcc are percentages. Formatting follows Table 1. These groups do not isolate length robustness.

Grouping by dataset source gives a similar comparison (Table 4). Across the 223 TCGA tasks, MI-Hyper achieves 56.68 AUC and 45.92 BAcc, gaining 2.98 and 2.87 points over MI-Zero and contributing substantially to the overall gains. The 52 additional-source tasks change by −0.41 and −4.11 points, while the 33 CPTAC tasks change by −2.20 and −2.02 points. Supplementary Fig. S2 links these source groups to the endpoints represented in each dataset. Source averages should be interpreted alongside endpoint composition. All groups use the common query set and established checkpoints, so these comparisons do not evaluate transfer to held-out dataset sources.

SourceTask NumAUC↑ MI-ZeroAUC↑ MI-HyperAUC↑ Δ (pp)BAcc↑ MI-ZeroBAcc↑ MI-HyperBAcc↑ Δ (pp)
TCGA22353.7056.68+2.9843.0545.92+2.87
Additional5269.1868.76-0.4148.6744.56-4.11
CPTAC3354.3352.13-2.2047.5945.56-2.02
All tasks30856.3858.24+1.8544.4945.66+1.17

Table 4. Results by dataset source. AUC and BAcc (%) with Task Num denoting the number of tasks. All 308 tasks are retained and equally weighted within each source. Source grouping does not alter the five-fold partition of 112 semantic groups. Formatting follows Table 1.

Beyond the aggregate gains, MI-Hyper produces larger improvements on some individual tasks. Table 5 reports AUC, BAcc and paired differences for six tasks spanning benign/malignant classification, molecular subtyping, mutation prediction and tumor grading. The display rule starts from all 308 tasks and requires at least 100 bags, at least 20 bags per class, and gains of at least ten percentage points in each of the three metrics reported in Supplementary Table S1. We rank eligible tasks by their smallest gain across the three metrics, retain the highest-ranked task in each anatomical group and show the first six. This display selection leaves the complete task set and overall scores unchanged.

TasknnAUC↑ MI-ZeroAUC↑ MI-HyperAUC↑ Δ (pp)BAcc↑ MI-ZeroBAcc↑ MI-HyperBAcc↑ Δ (pp)
Lung benign/malignant88869.4294.43+25.0165.5886.67+21.09
TCGA-ESCA subtype (CIN vs. ESCC)14176.9694.63+17.6762.1584.25+22.09
COAD ATRX mutation43442.3565.81+23.4645.9662.86+16.91
UCEC SETD2 mutation50546.4771.46+25.0047.9264.52+16.60
SKCM mRNA subtype29151.3665.59+14.2329.6945.04+15.34
HNSC grade42854.1967.22+13.0332.9148.51+15.60

Table 5. Six tasks with substantial gains. AUC and BAcc are percentages; nn is the number of bags. Higher scores are bold. Δ\Delta is MI-Hyper minus MI-Zero in percentage points, computed before rounding, with gains in green. The lung task is from REG_dataset; ESCA uses the source-defined labels CIN and ESCC. Each example has at least 100 bags and 20 bags per class; the selection rule is given in the text. All 308 tasks contribute to the overall results.

Lung benign/malignant classification reaches 94.43 AUC and 86.67 BAcc on 888 bags, gaining 25.01 and 21.09 points; its smallest class contains 126 bags. The source-defined TCGA-ESCA subtype task (CIN vs. ESCC) reaches 94.63 AUC and 84.25 BAcc on 141 bags, gaining 17.67 and 22.09 points. Both tasks improve in AUC and BAcc, reflecting concurrent gains in ranking and class decisions.

Molecular-marker tasks provide complementary examples. COAD ATRX AUC increases from 42.35 to 65.81, with a 16.91-point BAcc gain, while UCEC SETD2 gains 25.00 AUC and 16.60 BAcc points. These tasks contain 434 and 505 bags, with smallest classes of 32 and 62 bags. SKCM mRNA subtyping reaches 65.59 AUC and 45.04 BAcc, and HNSC grading reaches 67.22 AUC and 48.51 BAcc. Because starting scores and final performance differ across endpoints, the table retains absolute scores, paired changes and sample counts to place each improvement in context.

Across the complete collection, MI-Hyper improves AUC on 182 tasks and BAcc on 184 tasks. The median AUC change is +1.94 points, with tenth and ninetieth percentiles of −12.97 and +17.02. Supplementary Table S1 reports every task, allowing these larger gains to be viewed within the full result distribution.

Generated Queries and Spatial Attention

Figure 3a includes all 63 target tasks associated with the checkpoint used for the COAD examples. Within each task, we average the 21 pairwise cosine similarities among its seven condition-specific queries, yielding a task-average value of 0.992. For between-task comparisons, we average each task’s seven unit-normalized queries and normalize the resulting consensus. Each task is compared with the other 62 task consensuses; the task-average cosine similarity is 0.951. The consensus cosine between COAD histological diagnosis and ATRX mutation prediction is 0.848.

We next relate query differences to attention differences on the same patch sets across 18 WSIs from six TCGA datasets (Figure 3b). Query distance is the Euclidean distance divided by the mean query norm, d(q,r)=2∥q−r∥/(∥q∥2+∥r∥2)d(q,r) = 2\lVert q-r\rVert/(\lVert q\rVert_2 + \lVert r\rVert_2). Attention differences use base-2 Jensen–Shannon (JS) divergence. For each WSI, we average 49 cross-task or 21 within-task condition pairs, then average across three slides for each task or task pair. Spearman correlations across task-pair means and task means are 0.959 and 0.940, respectively. In these cases, query distance is positively associated with attention divergence.

Figure 3. Query similarities and attention maps. (a) Within- and between-task query cosine similarities for 63 tasks and the condition-level similarity matrix for the COAD diagnosis and ATRX mutation tasks. (b) Query distance and Jensen–Shannon divergence of attention distributions on 18 WSIs. Bars show the range across three cases; open markers denote same-label variants. (c) Two COAD WSIs, each shown with H&E and attention maps for histological diagnosis and ATRX mutation prediction. Each map is the mean of seven separately normalized attention distributions. Colors show Nαˉ\bar{N\alpha} (0.01–100): blue indicates lower and red higher relative attention; 1 denotes uniform attention. Scale bars: 1 mm.

Pooling depends on query direction and magnitude, but cosine similarity captures only direction. Positive rescaling can therefore change attention concentration without changing query direction. For two patches in the same bag, Eq. (5) gives log⁡(αi/αj)=qT⊤(gi−gj)\log(\alpha_i/\alpha_j) = q_T^\top(g_i-g_j). Consequently, a query change can alter relative patch weights through its projection onto the patch-feature difference, even when query directions remain close. Figure 3b therefore compares generated queries with the attention distributions they induce on fixed patch sets.

On each COAD WSI, histological diagnosis and ATRX mutation prediction use the same patches, generator and shared MIL basis (Figure 3c). The difference in relative tissue weights therefore arises from the generated task query. Supplementary Fig. S3 shows 16 distinct tasks and WSIs from six TCGA datasets, covering grading, molecular subtyping and mutation prediction. Unlike the COAD comparisons, each supplementary panel uses a different task and WSI.

Query–Classifier Recombination

Having related generated queries to spatial attention, we next examine how the query and classifier affect case-level ranking. We exchange their sources across four tasks: ARID1A and TP53 prediction in BLCA and UCEC (Figure 4). All combinations use the same frozen MIL basis and target-case features. Classifier rows are aligned by wildtype and mutant labels before exchange. We evaluate 891 cases and average metrics over seven separately evaluated text conditions.

Figure 4. Query–classifier recombination. Rows denote query donors and columns classifier (WW, bb) donors. B-A, B-T, U-A and U-T denote BLCA ARID1A, BLCA TP53, UCEC ARID1A and UCEC TP53. Cells give AUC or Bacc (%) averaged over seven conditions on complete target case pools. Purple outlines mark original pairs. Across genes, class rows align wildtype and mutant states.

For each target, we first keep its original classifier fixed and compare the AUC obtained with queries from all four tasks. The difference between the highest and lowest AUC averages 0.19 percentage points over the four targets. We then keep its original query fixed and exchange classifier weights and biases. This gives an average AUC range of

5.13 percentage points. Therefore, ranking performance is more sensitive to classifier source than to query source in these tasks.

Conclusion

Through mixed-task source training, MI-Hyper learns to generate the aggregation and classification weights of MIL predictors from pathology task descriptions. Across 308 tasks from 52 pathology datasets, its mean AUC and balanced accuracy exceed those of MI-Zero, with substantial concurrent gains on some endpoints. These findings provide experimental support for constructing WSI predictors from task descriptions. Generating one predictor per text condition and reusing it across cases offers a promising route to weight-space transfer for long visual sequences.

Future work should broaden source-task coverage and investigate data augmentation. More stable weight generation will also be important for reliable prediction.

LLM Usage Statement

We used OpenAI Codex to revise the manuscript, check experimental settings and result records, and prepare tables and figures from saved measurements. All reported performance values come from existing evaluation files; none are simulated. The source package includes results and verification scripts. Schematics use real WSI thumbnails and matching crops; prediction bars and model components are illustrative. Displayed task examples are subsets of the complete results, and parameter counts and computational analyses are not runtime measurements. The authors are responsible for verifying the scientific content, citations and final submission.

Supplementary Material

Datasets and Task Distribution

A task is a dataset–endpoint pair, so the same endpoint in different datasets defines distinct tasks. Figure S1 groups the tasks by anatomy, endpoint type and dataset source. Mutation prediction and staging account for 122 and 69 tasks, respectively. Colorectal tasks form the largest anatomical group, with 37 tasks; lymph node and thymus each contain one. These unequal group sizes motivate the endpoint, anatomy and source summaries in the main text.

All comparisons use the same 308 tasks and complete query records. MI-Hyper uses the fixed five-fold checkpoints for 112 semantic groups. The registry contains 160,989 task–bag records and 29,481 recorded patient IDs; task–bag counts can repeat cases that support multiple endpoints. The 52 dataset entries include merged collections and subsets and therefore do not represent 52 independent clinical cohorts.

Figure S2 shows which endpoints are represented in each dataset: TCGA contributes 223 tasks, CPTAC 33 and the additional datasets 52. Because endpoint composition differs across sources, the main-text source averages reflect different task collections. The catalogue uses the same dataset and task identifiers as Table S1, linking each group mean to its constituent endpoints.

Figure S2. Endpoint coverage by dataset. (a) 30 TCGA datasets and 223 tasks. (b) 11 CPTAC datasets and 33 tasks. (c) 11 additional datasets and 52 tasks. Each card identifies a dataset and its task count; colored tags give nonzero counts for each endpoint type. All 52 datasets and 308 tasks are retained, including registered merged collections and subsets. Card area does not encode sample size.

For anatomical displays and performance summaries, we merge colon, colorectal and colorectum as Colorectal; prostate and prostate gland as Prostate; and cervix and uterine cervix as Cervix. These display-only merges leave original task IDs, anatomical labels and training and evaluation assignments unchanged.

Attention Maps Across Tasks

Figure S3 pairs H&E images with task-specific attention maps for 16 tasks from six TCGA datasets. Each pair uses the same WSI and field of view, with the fixed models, complete patch sets and seven-condition averaging of the main evaluation. Slides are chosen by fixed patient-ordering and file-availability rules.

These panels show different tasks and WSIs; main-text Figure 3c compares tasks on the same slide. Region-level pathology annotations were unavailable for these examples.

Figure S3. H&E images and attention maps across tasks. a TCGA-BRCA | PIK3CA mutation; b TCGA-COAD | Histological diagnosis; c TCGA-UCEC | Tumor grade; d TCGA-LUAD | CDKN2A mutation; e TCGA-LUSC | RB1 mutation; f TCGA-STAD | ARID1A mutation; g TCGA-BRCA | mRNA subtype; h TCGA-COAD | ATRX mutation. Each panel pairs H&E (left) and attention (right) for the same WSI field. Panels (a)–(h) appear here; (i)–(p) continue on the next page. Maps average seven separately normalized attention distributions. Colors show relative attention, NαˉN\bar{\alpha}, on a logarithmic scale (0.01–100): blue is lower, red higher. Scale bars: 1 mm. Relative attention (N×N \times weight); ≤0.01\le0.01; ≥100\ge100.

Figure S3 (PDF p. 15). H&E images and attention maps across tasks (continued). Panels (i)–(p). H&E images and corresponding attention maps use matched fields of view. Text-condition averaging, color scale and scale bars follow panels (a)–(h).

Complete-Bag Inference

For the gated implementation, the cached task-specific parameters contain

a+Cτ(h+1)=128+257Cτ(9)a + C_{\tau}(h + 1) = 128 + 257C_{\tau} \tag*{(9)}

scalars. Their number depends on the class vocabulary rather than bag length. The shared basis, pretrained encoders and patch features are stored separately.

To apply the predictor to every stored patch, we process long bags in chunks while maintaining a single global attention normalization. Let mm, ss and uu denote the running maximum score, normalization sum and weighted feature sum. For a new chunk B\mathcal{B}, the updates are

m′=max⁡{m,max⁡i∈Bri},s′=exp⁡(m−m′)s+∑i∈Bexp⁡(ri−m′),u′=exp⁡(m−m′)u+∑i∈Bexp⁡(ri−m′)vi.(10)\begin{aligned} m' &= \max\left\{m,\max_{i\in\mathcal{B}} r_i\right\},\\ s' &= \exp(m-m')s+\sum_{i\in\mathcal{B}}\exp(r_i-m'),\\ u' &= \exp(m-m')u+\sum_{i\in\mathcal{B}}\exp(r_i-m')v_i. \tag*{(10)} \end{aligned}

The state is initialized from the first chunk, and the final aggregated representation is vX=u/sv_X = u/s. The recurrence uses all stored patches for globally normalized pooling, up to floating-point rounding. Training samples at most 2048 patches per bag to control cost; chunking instead executes each complete query bag.

Results for All 308 Tasks

Table S1 extends the grouped AUC and BAcc comparisons in the main text to AUC, BAcc and macro-F1 for every task. MI-Zero includes five pooling settings and Mean-KK; MI-Hyper averages metrics across seven predefined conditions. Both methods use the same query list for each task, and MI-Hyper uses its fixed model without target-label selection of text conditions. Class and bag counts are calculated from this query list.

MI-Hyper averages 58.24% AUC, 45.66% BAcc and 36.05% F1 across tasks, compared with 56.38%, 44.49% and 35.48% for MI-Zero. The table includes results favoring either method, so readers can relate the overall and grouped means to individual endpoints. Blue task IDs mark the six main-text examples with concurrent gains; this display subset does not change the overall statistics.

References

  1. [1]Victor Akinwande, Mohammad Sadegh Norouzzadeh, Devin Willmott, Anna Bair, Madan Ravi Ganesh, and J Zico Kolter. HyperCLIP: Prompt-conditioned image encoders for contrastive vision-language pre-training. Transactions on Machine Learning Research, 2026. 2
  2. [2]Ohad Amosy, Tomer Volk, Eilam Shapira, Eyal Ben-David, Roi Reichart, and Gal Chechik. Text2Model: Text-based model induction for zero-shot image classification. In Findings of the Association for Computational Linguistics: EMNLP 2024, pages 155–172. Association for Computational Linguistics, 2024. 1, 2
  3. [3]Jimmy Lei Ba, Kevin Swersky, Sanja Fidler, and Ruslan Salakhutdinov. Predicting deep zero-shot convolutional neural networks using textual descriptions. In Proceedings of the IEEE International Conference on Computer Vision, pages 4247–4255, 2015. 2arxiv.org/abs/1506.00511
  4. [4]Sudarshan Babu, Richard Liu, Avery Zhou, Michael Maire, Greg Shakhnarovich, and Rana Hanocka. HyperFields: Towards zero-shot generation of NeRFs from text. In Proceedings of the 41st International Conference on Machine Learning, pages 2230–2247. PMLR, 2024. 2arxiv.org/abs/2310.17075
  5. [5]Gabriele Campanella, Matthew G. Hanna, Luke Geneslaw, Allen Miraflor, Vitor Wernick Krauss Silva, Klaus J. Busam, Edi Brogi, Victor E. Reuter, David S. Klimstra, and Thomas J. Fuchs. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nature Medicine, 25:1301–1309, 2019. 2DOI
  6. [6]Rujikorn Charakorn, Edoardo Cetin, Yujin Tang, and Robert Tjarko Lange. Text-to-LoRA: Instant transformer adaptation. In Proceedings of the 42nd International Conference on Machine Learning, pages 7485–7514. PMLR, 2025. 1, 2arxiv.org/abs/2506.06105
  7. [7]Richard J. Chen, Chengkuan Chen, Yicong Li, Tiffany Y. Chen, Andrew D. Trister, Rahul G. Krishnan, and Faisal Mahmood. Scaling vision transformers to gigapixel images via hierarchical self-supervised learning. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pages 16144–16155, 2022. 2arxiv.org/abs/2206.02647
  8. [8]Richard J. Chen, Tong Ding, Ming Y. Lu, Drew F. K. Williamson, Guillaume Jaume, Andrew H. Song, Bowen Chen, Andrew Zhang, Daniel Shao, Muhammad Shaban, Mane Williams, Lukas Oldenburg, Luca L. Weishaupt, Judy J. Wang, Anurag Vaidya, Long Phi Le, Georg Gerber, Sharifa Sahai, Walt Williams, and Faisal Mahmood. Towards a general-purpose foundation model for computational pathology. Nature Medicine, 30:850–862, 2024. 2DOI
  9. [9]Weiming Chen, Xitong Ling, Zhenyang Cai, Xidong Wang, Jiawen Li, Tian Guan, Benyou Wang, and Yonghong He. Beyond ViT Tokens: Masked-diffusion pretrained convolutional pathology foundation model for cell-level dense prediction. In Conference on Neural Information Processing Systems, 2026. Poster. 2arxiv.org/abs/2605.08276
  10. [10]Nicolas Coudray, Paolo Santiago Ocampo, Theodore Sakellaropoulos, Navneet Narula, Matija Snuderl, David Fenyö, Andre L. Moreira, Narges Razavian, and Aristotelis Tsirigos. Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning. Nature Medicine, 24:1559–1567, 2018. 2DOI
  11. [11]Tong Ding, Sophia J. Wagner, Andrew H. Song, Richard J. Chen, Ming Y. Lu, Andrew Zhang, Anurag J. Vaidya, Guillaume Jaume, Muhammad Shaban, Ahron Kim, Drew F. K. Williamson, Harry Robertson, Bowen Chen, Cristina Almagro-Pérez, Paul Doucet, Sharifa Sahai, Chengkuan Chen, Christina S. Chen, Daisuke Komura, Akihiro Kawabe, Mieko Ochi, Shinya Sato, Tomoyuki Yokose, Yohei Miyagi, Shumpei Ishikawa, Georg Gerber, Tingying Peng, Long Phi Le, and Faisal Mahmood. A multimodal whole-slide foundation model for pathology. Nature Medicine, 31:3749–3761, 2025. 1, 2DOI
  12. [12]Mohamed Elhoseiny, Babak Saleh, and Ahmed Elgammal. Write a classifier: Zero-shot learning using purely textual descriptions. In Proceedings of the IEEE International Conference on Computer Vision, pages 2584–2591, 2013. 2DOI
  13. [13]Mingxi Fu, Xitong Ling, Yuxuan Chen, Jiawen Li, Fanglei Fu, Huaitian Yuan, Tian Guan, Yonghong He, and Lianghui Zhu. Deformable attention graph representation learning for histopathology whole slide image analysis. In ICASSP 2026 - 2026 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), pages 6471–6475. IEEE, 2026. 2
  14. [14]David Ha, Andrew Dai, and Quoc V. Le. HyperNetworks. In International Conference on Learning Representations, 2017. 1, 2arxiv.org/abs/1609.09106
  15. [15]Yun He, Steven Zheng, Yi Tay, Jai Gupta, Yu Du, Vamsi Aribandi, Zhe Zhao, Yaguang Li, Zhao Chen, Donald Metzler, Heng-Tze Cheng, and Ed H. Chi. HyperPrompt: Prompt-based task-conditioning of transformers. In Proceedings of the 39th International Conference on Machine Learning, pages 8678–8690. PMLR, 2022. 2arxiv.org/abs/2203.00759
  16. [16]Edward J. Hu, Yelong Shen, Phillip Wallis, Zeyuan Allen-Zhu, Yuanzhi Li, Shean Wang, Lu Wang, and Weizhu Chen. LoRA: Low-rank adaptation of large language models. In International Conference on Learning Representations, 2022. 2arxiv.org/abs/2106.09685
  17. [17]Zhi Huang, Federico Bianchi, Mert Yuksekgonul, Thomas J. Montine, and James Zou. A visual–language foundation model for pathology image analysis using medical Twitter. Nature Medicine, 29:2307–2316, 2023. 2DOI
  18. [18]Maximilian Ilse, Jakub Tomczak, and Max Welling. Attention-based deep multiple instance learning. In Proceedings of the 35th International Conference on Machine Learning, pages 2127–2136. PMLR, 2018. 1, 2
  19. [19]Hamish Ivison, Akshita Bhagia, Yizhong Wang, Hannah Hajishirzi, and Matthew Peters. HINT: Hypernetwork instruction tuning for efficient zero- and few-shot generalisation. In Proceedings of the 61st Annual Meeting of the Association for Computational Linguistics (Volume 1: Long Papers), pages 11272–11288. Association for Computational Linguistics, 2023. 2
  20. [20]Sajid Javed, Arif Mahmood, Iyyakutti Iyappan Ganapathi, Fayaz Ali Dharejo, Naoufel Werghi, and Mohammed Benamoun. CLIP: Zero-shot learning for histopathology with comprehensive vision-language alignment. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pages 11450–11459, 2024. 2arxiv.org/abs/2406.05205
  21. [21]Rabeeh Karimi Mahabadi, Sebastian Ruder, Mostafa Dehghani, and James Henderson. Parameter-efficient multi-task fine-tuning of transformers via shared hypernetworks. In Proceedings of the 59th Annual Meeting of the Association for Computational Linguistics and the 11th International Joint Conference on Natural Language Processing (Volume 1: Long Papers), pages 565–576. Association for Computational Linguistics, 2021. 2
  22. [22]Jakob Nikolas Kather, Alexander T. Pearson, Niels Halama, Dirk Jäger, Jeremias Krause, Sven H. Loosen, Alexander Marx, Peter Boor, Frank Tacke, Ulf Peter Neumann, Heike I. Grabsch, Takaki Yoshikawa, Hermann Brenner, Jenny Chang-Claude, Michael Hoffmeister, Christian Trautwein, and Tom Luedde. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nature Medicine, 25:1054–1056, 2019. 2DOI
  23. [23]Juho Lee, Yoonho Lee, Jungtaek Kim, Adam Kosiorek, Seungjin Choi, and Yee Whye Teh. Set transformer: A framework for attention-based permutation-invariant neural networks. In Proceedings of the 36th International Conference on Machine Learning, pages 3744–3753. PMLR, 2019. 2arxiv.org/abs/1810.00825
  24. [24]Bin Li, Yin Li, and Kevin W. Eliceiri. Dual-stream multiple instance learning network for whole slide image classification with self-supervised contrastive learning. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pages 14318–14328, 2021. 2DOI
  25. [25]Jiawen Li, Yuxuan Chen, Hongbo Chu, Qiehe Sun, Tian Guan, Anjia Han, and Yonghong He. Dynamic graph representation with knowledge-aware attention for histopathology whole slide image analysis. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pages 11323–11332, 2024.arxiv.org/abs/2403.07719
  26. [26]Xitong Ling, Minxi Ouyang, Yizhi Wang, Xinrui Chen, Rennao Yan, Hongbo Chu, Junru Cheng, Tian Guan, Sufang Tian, Xiaoping Liu, and Yonghong He. Agent aggregator with mask denoise mechanism for histopathology whole slide image analysis. In Proceedings of the 32nd ACM International Conference on Multimedia, pages 2795–2803. ACM, 2024. 2DOI
  27. [27]Xitong Ling, Yuanyuan Lei, Jiawen Li, Junru Cheng, Went-ing Huang, Tian Guan, Jian Guan, and Yonghong He. Comprehensive Benchmark Dataset for Pathological Lymph Node Metastasis in Breast Cancer Sections. Scientific Data, 12(1): 1381, 2025. 2DOI
  28. [28]Pei Liu, Xiangxiang Zeng, Tengfei Ma, Yucheng Xing, Xuanbai Ren, and Yiping Liu. Sparse task vector mixup with hyper-networks for efficient knowledge transfer in whole-slide image prognosis. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pages 35238–35247, 2026. 3
  29. [29]Ilya Loshchilov and Frank Hutter. Decoupled weight decay regularization. In International Conference on Learning Representations, 2019. 4
  30. [30]Ming Y. Lu, Drew F. K. Williamson, Tiffany Y. Chen, Richard J. Chen, Matteo Barbieri, and Faisal Mahmood. Data-efficient and weakly supervised computational pathology on whole-slide images. Nature Biomedical Engineering, 5:555–570, 2021. 1, 2DOI
  31. [31]Ming Y. Lu, Bowen Chen, Andrew Zhang, Drew F. K. Williamson, Richard J. Chen, Tong Ding, Long Phi Le, Yung-Sung Chuang, and Faisal Mahmood. Visual language pre-trained multiple instance zero-shot transfer for histopathology images. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pages 19764–19775, 2023. 1, 2
  32. [32]Ming Y. Lu, Bowen Chen, Drew F. K. Williamson, Richard J. Chen, Ivy Liang, Tong Ding, Guillaume Jaume, Igor Odintsov, Long Phi Le, Georg Gerber, Anil V. Parwani, Andrew Zhang, and Faisal Mahmood. A visual-language foundation model for computational pathology. Nature Medicine, 30:863–874, 2024. 1, 2DOI
  33. [33]Elvis Nava, Seijin Kobayashi, Yifei Yin, Robert K. Katzschmann, and Benjamin F. Grewe. Meta-learning via classifier(-free) diffusion guidance. Transactions on Machine Learning Research, 2023. 2arxiv.org/abs/2210.08942
  34. [34]Alec Radford, Jong Wook Kim, Chris Hallacy, Aditya Ramesh, Gabriel Goh, Sandhini Agarwal, Girish Sastry, Amanda Askell, Pamela Mishkin, Jack Clark, Gretchen Krueger, and Ilya Sutskever. Learning transferable visual models from natural language supervision. In Proceedings of the 38th International Conference on Machine Learning, pages 8748–8763. PMLR, 2021. 2arxiv.org/abs/2103.00020
  35. [35]Scott Reed, Zeynep Akata, Honglak Lee, and Bernt Schiele. Learning deep representations of fine-grained visual descriptions. In Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, pages 49–58, 2016. 2arxiv.org/abs/1605.05395
  36. [36]George Shaikovski, Adam Casson, Kristen Severson, Eric Zimmermann, Yi Kan Wang, Jeremy D. Kunz, Juan A. Retamero, Gerard Oakley, David Klimistra, Christopher Kanan, Matthew Hanna, Michal Zelechowski, Julian Viret, Neil Tenenholtz, James Hall, Nicolo Fusi, Razik Yousfi, Peter Hamilton, William A. Moye, Eugene Vorontsov, Siqi Liu, and Thomas J. Fuchs. PRISM: A multi-modal generative foundation model for slide-level histopathology. arXiv preprint arXiv:2405.10254, 2024. 2arxiv.org/abs/2405.10254
  37. [37]Daniel Shao, Dongmin Bang, Luca L. Weishaupt, Sophia J. Wagner, Nic G. Reitsam, Ming Y. Lu, Long P. Le, Richard J. Chen, and Faisal Mahmood. Beyond sparse captions: Aligning slide-level text and patch-level vision in pathology. In Zhuchen Shao, Hao Bian, Yang Chen, Yifeng Wang, Jian Zhang, Xiangyang Ji, and Yongbing Zhang. TransMIL: Transformer based correlated multiple instance learning for whole slide image classification. In Advances in Neural Information Processing Systems, pages 2136–2147, 2021.
  38. [39]Eugene Vorontsov, Alican Bozkurt, Adam Casson, George Shaikovski, Michal Zelechowski, Kristen Severson, Eric Zimmermann, James Hall, Neil Tenenholtz, Nicolo Fusi, Ellen Yang, Philippe Mathieu, Alexander van Eck, Donghun Lee, Julian Viret, Eric Robert, Yi Kan Wang, Jeremy D. Kunz, Matthew C. H. Lee, Jan H. Bernhard, Ran A. Godrich, Gerard Oakley, Ewan Millar, Matthew Hanna, Hannah Wen, Juan A. Retamero, William A. Moye, Razik Yousfi, Christopher Kanan, David S. Klimstra, Brandon Rothrock, Siqi Liu, and Thomas J. Fuchs. A foundation model for clinical-grade computational pathology and rare cancers detection. Nature Medicine, 30:2924–2935, 2024.DOI
  39. [40]Eugene Vorontsov, George Shaikovski, Adam Casson, Julian Viret, Eric Zimmermann, Neil Tenenholtz, Yi Kan Wang, Jan H. Bernhard, Ran A. Godrich, Juan A. Retamero, Jinru Shia, Mifhat Gonen, Martin R. Weiser, David S. Klimstra, Razik Yousfi, Nicolò Fusi, Thomas J. Fuchs, Kristen Severson, and Siqi Liu. End-to-end multimodal pathology foundation model with clinical dialogue. Nature Medicine, 32:3203–3213, 2026.DOI
  40. [41]Xiyue Wang, Sen Yang, Jun Zhang, Minghui Wang, Jing Zhang, Wei Yang, Junzhou Huang, and Xiao Han. Transformer-based unsupervised contrastive learning for histopathological image classification. Medical Image Analysis, 81:102559, 2022.DOI
  41. [42]Xiyue Wang, Yuexi Du, Sen Yang, Jun Zhang, Minghui Wang, Jing Zhang, Wei Yang, Junzhou Huang, and Xiao Han. RetCCL: Clustering-guided contrastive learning for whole-slide image retrieval. Medical Image Analysis, 83:102645, 2023.DOI
  42. [43]Xiyue Wang, Junhan Zhao, Eliana Marostica, Wei Yuan, Jietian Jin, Jiayu Zhang, Ruijian Li, Hongping Tang, Kanran Wang, Yu Li, Fang Wang, Yulong Peng, Junyou Zhu, Jing Zhang, Christopher R. Jackson, Jun Zhang, Deborah Dillon, Nancy U. Lin, Lynette Sholl, Thomas Denize, David Meredith, Keith L. Ligon, Sabina Signoretti, Shuji Ogino, Jeffrey A. Golden, MacLean P. Nasrallah, Xiao Han, Sen Yang, and Kun-Hsing Yu. A pathology foundation model for cancer diagnosis and prognosis prediction. Nature, 634:970–978, 2024.DOI
  43. [44]Hanwen Xu, Naoto Usuyama, Jaspreet Bagga, Sheng Zhang, Rajesh Rao, Tristan Naumann, Cliff Wong, Zelalem Gero, Javier González, Yu Gu, Yanbo Xu, Muwei Wei, Wenhui Wang, Shuming Ma, Furu Wei, Jianwei Yang, Chunyuan Li, Jianfeng Gao, Jaylen Rosemon, Tucker Bower, Soohee Lee, Roshanthi Weerasinghe, Bill J. Wright, Ari Robicsek, Brian Piening, Carlo Bifulco, Sheng Wang, and Hoifung Poon. A whole-slide foundation model for digital pathology from real-world data. Nature, 630:181–188, 2024.DOI
  44. [45]Fang Yan, Jianfeng Wu, Jianwei Li, Wei Wang, Yirong Chen, Linda Wei, Jiaxuan Lu, Wen Chen, Zizhao Gao, Jinnan Li, Heng Li, Hong Yan, Jiabo Ma, Minda Chen, Yang Lu, Qing Chen, Yizhi Wang, Xitong Ling, Xuenian Wang, Zihan Wang, Qiang Huang, Shengyi Hua, Mianxin Liu, Lei Ma, Tian Shen, Xiaofan Zhang, Yonghong He, Hao Chen, Shaoting Zhang, and Zhe Wang. PathOrchestra: a comprehensive foundation model for computational pathology with over 100 diverse clinical-grade tasks. npj Digital Medicine, 8(1):695, 2025.arxiv.org/abs/2503.24345
  45. [46]Manzil Zaheer, Satwik Kottur, Siamak Ravanbakhsh, Barnabas Poczos, Ruslan Salakhutdinov, and Alexander J. Smola. Deep Sets. In Advances in Neural Information Processing Systems, pages 3391–3401, 2017.
  46. [47]Di Zhang, Zhangpeng Gong, Xiaobo Pang, Jiashuai Liu, Junbo Lu, Hao Cui, Jiusong Ge, Zhi Zeng, Kai Yi, Yinghua Li, Si Liu, Tingsong Yu, Haoran Wang, Mireia Crispin-Ortuzar, Weimiao Yu, Chen Li, and Zeyu Gao. CARE: A molecular-guided foundation model with adaptive region modeling for whole slide image analysis. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pages 21078–21088, 2026.arxiv.org/abs/2602.21637
  47. [48]Hongrun Zhang, Yanda Meng, Yitian Zhao, Yihong Qiao, Xiaoyun Yang, Sarah E. Coupland, and Yanin Zheng. DTFD-MIL: Double-tier feature distillation multiple instance learning for histopathology whole slide image classification. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pages 18802–18812, 2022.arxiv.org/abs/2203.12081
  48. [49]Sheng Zhang, Yanbo Xu, Naoto Usuyama, Hanwen Xu, Jaspreet Bagga, Robert Tinn, Sam Preston, Rajesh Rao, Mu Wei, Naveen Valluri, Clift Wong, Andrea Tupini, Yu Wang, Matt Mazzola, Swadheen Shukla, Lars Liden, Jianfeng Gao, Angela Crabtree, Brian Piening, Carlo Bifulco, Matthew P. Lungren, Tristan Naumann, Sheng Wang, and Hoifung Poon. A multimodal biomedical foundation model trained from fifteen million image–text pairs. NEJM AI, 2(1):AIoa2400640, 2025.DOI
  49. [50]Kaiyang Zhou, Jingkang Yang, Chen Change Loy, and Ziwei Liu. Conditional prompt learning for vision-language models. In Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pages 16816–16825, 2022.arxiv.org/abs/2203.05557
  50. [51]Kaiyang Zhou, Jingkang Yang, Chen Change Loy, and Ziwei Liu. Learning to prompt for vision-language models. International Journal of Computer Vision, 130(9):2337–2348, 2022.DOI
  51. [52]Lianghui Zhu, Xitong Ling, Minxi Ouyang, Xiaoping Liu, Tian Guan, Mingxi Fu, Maomao Zeng, Zhiqiang Cheng, Fanglei Fu, Qiang Huang, Mingxi Zhu, Yibo Jin, Qiming He, Yizhi Wang, Junru Cheng, Xuanyu Wang, Luxi Xie, Houqiang Li, Sufang Tian, and Yonghong He. Subspecialty-specific foundation model for intelligent gastrointestinal pathology. npj Digital Medicine, 9(1):473, 2026.
  52. [53]Eric Zimmermann, Eugene Vorontsov, Julian Viret, Adam Casson, Michal Zelechowski, George Shaikovski, Neil Tenenholtz, James Hall, David Klimstra, Razik Yousfi, Thomas Fuchs, Nicolo Fusi, Siqi Liu, and Kristen Severson. chow2: Scaling self-supervised mixed magnification models in pathology. arXiv preprint arXiv:2408.00738, 2024.arxiv.org/abs/2408.00738

Paper details

vlnc:W_53ck8dm5
Version
v1 · latest
Published
Fresh — added to the Hub within the last 30 days
Added
License
CC0-1.0
Usage

views · 0

downloads · 0

A view counts once per browser per day, a download each time the PDF is requested.

  • Computer Science

Codex

View statement
Looking for related papers…
Contents